The	O
glucocorticoid	B-protein
receptor	I-protein
cooperates	O
with	O
the	O
erythropoietin	B-protein
receptor	I-protein
and	O
c-Kit	B-protein
to	O
enhance	O
and	O
sustain	O
proliferation	O
of	O
erythroid	B-cell_type
progenitors	I-cell_type
in	O
vitro	O
.	O

Although	O
erythropoietin	B-protein
(	O
Epo	B-protein
)	O
is	O
essential	O
for	O
the	O
production	O
of	O
mature	B-cell_type
red	I-cell_type
blood	I-cell_type
cells	I-cell_type
,	O
the	O
cooperation	O
with	O
other	O
factors	O
is	O
required	O
for	O
a	O
proper	O
balance	O
between	O
progenitor	O
proliferation	O
and	O
differentiation	O
.	O

In	O
avian	O
erythroid	B-cell_type
progenitors	I-cell_type
,	O
steroid	O
hormones	O
cooperate	O
with	O
tyrosine	B-protein
kinase	I-protein
receptors	I-protein
to	O
induce	O
renewal	O
of	O
erythroid	B-cell_type
progenitors	I-cell_type
.	O

We	O
examined	O
the	O
role	O
of	O
corticosteroids	O
in	O
the	O
in	O
vitro	O
expansion	O
of	O
primary	B-cell_type
human	I-cell_type
erythroid	I-cell_type
cells	I-cell_type
in	O
liquid	O
cultures	O
and	O
colony	O
assays	O
.	O

Dexamethasone	O
(	O
Dex	O
)	O
,	O
a	O
synthetic	O
glucocorticoid	O
hormone	O
,	O
cooperated	O
with	O
Epo	B-protein
and	O
stem	B-protein
cell	I-protein
factor	I-protein
to	O
induce	O
erythroid	B-cell_type
progenitors	I-cell_type
to	O
undergo	O
15	O
to	O
22	O
cell	O
divisions	O
,	O
corresponding	O
to	O
a	O
10	O
(	O
5	O
)	O
-	O
to	O
10	O
(	O
6	O
)	O
-fold	O
amplification	O
of	O
erythroid	B-cell_type
cells	I-cell_type
.	O

Dex	O
acted	O
directly	O
on	O
erythroid	B-cell_type
progenitors	I-cell_type
and	O
maintained	O
the	O
colony-forming	O
capacity	O
of	O
the	O
progenitor	B-cell_type
cells	I-cell_type
expanded	O
in	O
liquid	B-cell_line
cultures	I-cell_line
.	O

The	O
hormone	O
delayed	O
terminal	O
differentiation	O
into	O
erythrocytes	B-cell_type
,	O
which	O
was	O
assayed	O
by	O
morphology	O
,	O
hemoglobin	B-protein
accumulation	O
,	O
and	O
the	O
expression	O
of	O
genes	O
characteristic	O
for	O
immature	B-cell_type
cells	I-cell_type
.	O

Sustained	O
proliferation	O
of	O
erythroid	B-cell_type
progenitors	I-cell_type
could	O
be	O
induced	O
equally	O
well	O
from	O
purified	B-cell_line
erythroid	I-cell_line
burst-forming	I-cell_line
units	I-cell_line
(	O
BFU-E	B-cell_line
)	O
,	O
from	O
CD34	B-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
blast	I-cell_type
cells	I-cell_type
,	O
and	O
from	O
bone	O
marrow	O
depleted	O
from	O
CD34	B-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
cells	I-cell_type
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HEMATOPOIESIS	NULL
The	NULL
Glucocorticoid	NULL
Receptor	NULL
Cooperates	NULL
With	NULL
the	NULL
Erythropoietin	NULL
Receptor	NULL
and	NULL
c-Kit	NULL
to	NULL
Enhance	NULL
and	NULL
Sustain	NULL
Proliferation	NULL
of	NULL
Erythroid	NULL
Progenitors	NULL
In	NULL
Vitro	NULL
By	NULL
Marieke	NULL
von	NULL
Lindern	NULL
,	NULL
Wolfgang	NULL
Zauner	NULL
,	NULL
Georg	NULL
Mellitzer	NULL
,	NULL
Peter	NULL
Steinlein	NULL
,	NULL
Gerhard	NULL
Fritsch	NULL
,	NULL
Klaus	NULL
Huber	NULL
,	NULL
Bob	NULL
Lowenberg	NULL
,	NULL
and	NULL
Hartmut	NULL
Beug	NULL
Although	NULL
erythropoietin	NULL
(	NULL
Epo	NULL
)	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
production	NULL
of	NULL
mature	NULL
red	NULL
blood	NULL
cells	NULL
,	NULL
the	NULL
cooperation	NULL
with	NULL
other	NULL
factors	NULL
is	NULL
required	NULL
for	NULL
a	NULL
proper	NULL
balance	NULL
between	NULL
progenitor	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

In	NULL
avian	NULL
erythroid	NULL
progenitors	NULL
,	NULL
steroid	NULL
hormones	NULL
cooperate	NULL
with	NULL
tyrosine	NULL
kinase	NULL
receptors	NULL
to	NULL
induce	NULL
renewal	NULL
of	NULL
erythroid	NULL
progenitors	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
corticosteroids	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
expansion	NULL
of	NULL
primary	NULL
human	NULL
erythroid	NULL
cells	NULL
in	NULL
liquid	NULL
cultures	NULL
and	NULL
colony	NULL
assays	NULL
.	NULL

Dexamethasone	NULL
(	NULL
Dex	NULL
)	NULL
,	NULL
a	NULL
synthetic	NULL
glucocorticoid	NULL
hormone	NULL
,	NULL
cooperated	NULL
w	NULL
ith	NULL
Epo	NULL
and	NULL
stem	NULL
cell	NULL
factor	NULL
to	NULL
induce	NULL
erythroid	NULL
progenitors	NULL
to	NULL
undergo	NULL
15	NULL
to	NULL
22	NULL
cell	NULL
divisions	NULL
,	NULL
corresponding	NULL
HE	NULL
DEVELOPMENT	NULL
OF	NULL
mature	NULL
,	NULL
peripheral	NULL
blood	NULL
cells	NULL
from	NULL
pluripotent	NULL
stem	NULL
cells	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
is	NULL
a	NULL
complex	NULL
process	NULL
in	NULL
which	NULL
lineage	NULL
commitment	NULL
,	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
cell	NULL
survival	NULL
have	NULL
to	NULL
be	NULL
perfectly	NULL
balanced	NULL
.	NULL

Pluripotent	NULL
stem	NULL
cells	NULL
are	NULL
maintained	NULL
via	NULL
self	NULL
renewal	NULL
(	NULL
ie	NULL
,	NULL
proliferation	NULL
without	NULL
detectable	NULL
entry	NULL
of	NULL
a	NULL
differentiation	NULL
path-way	NULL
)	NULL
,	NULL
while	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
they	NULL
are	NULL
able	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
multipotent	NULL
and	NULL
committed	NULL
progenitors	NULL
.	NULL

The	NULL
latter	NULL
progenitors	NULL
differentiate	NULL
along	NULL
a	NULL
specific	NULL
cell	NULL
lineage	NULL
(	NULL
s	NULL
)	NULL
in	NULL
a	NULL
process	NULL
thought	NULL
to	NULL
occur	NULL
according	NULL
to	NULL
a	NULL
fixed	NULL
program	NULL
,	NULL
dictating	NULL
both	NULL
the	NULL
remaining	NULL
number	NULL
of	NULL
cell	NULL
divisions	NULL
and	NULL
the	NULL
time	NULL
of	NULL
entry	NULL
into	NULL
terminal	NULL
differentiation	NULL
.	NULL

Because	NULL
of	NULL
genetic	NULL
changes	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
commitment	NULL
and	NULL
differentiation	NULL
is	NULL
disregulated	NULL
in	NULL
leukemia	NULL
.	NULL

Leukemic	NULL
transformation	NULL
of	NULL
avian	NULL
erythroid	NULL
progenitors	NULL
by	NULL
the	NULL
oncoproteins	NULL
v-ErbA	NULL
and	NULL
v-ErbB	NULL
,	NULL
present	NULL
in	NULL
avian	NULL
erythroblastosis	NULL
virus	NULL
,	NULL
appeared	NULL
to	NULL
be	NULL
based	NULL
on	NULL
a	NULL
mechanism	NULL
that	NULL
is	NULL
latently	NULL
present	NULL
in	NULL
normal	NULL
cells	NULL
.	NULL
``	NULL

Normal	NULL
avian	NULL
erythroid	NULL
progenitors	NULL
express	NULL
tyrosine	NULL
kinase	NULL
receptors	NULL
related	NULL
to	NULL
v-ErbB	NULL
(	NULL
ie	NULL
,	NULL
c-ErbB	NULL
and	NULL
c-Kit	NULL
,	NULL
using	NULL
transforming	NULL
growth	NULL
factor	NULL
a	NULL
[	NULL
TGFa	NULL
]	NULL
and	NULL
avian	NULL
stem	NULL
cell	NULL
factor	NULL
[	NULL
SCF	NULL
]	NULL
as	NULL
ligands	NULL
)	NULL
and	NULL
nuclear	NULL
hormone	NULL
receptors	NULL
with	NULL
a	NULL
function	NULL
similar	NULL
to	NULL
v-ErbA	NULL
(	NULL
estrogen	NULL
receptor	NULL
and	NULL
glucocorticoid	NULL
receptor	NULL
)	NULL
.	NULL
``	NULL

Simultaneous	NULL
stimulation	NULL
of	NULL
these	NULL
two	NULL
receptor	NULL
types	NULL
in	NULL
normal	NULL
bone	NULL
marrow	NULL
cells	NULL
results	NULL
in	NULL
the	NULL
outgrowth	NULL
of	NULL
committed	NULL
erythroid	NULL
progenitors	NULL
that	NULL
From	NULL
the	NULL
Institute	NULL
of	NULL
Hematology	NULL
,	NULL
Erasmus	NULL
University	NULL
,	NULL
Rotterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
;	NULL
the	NULL
Institute	NULL
of	NULL
Molecular	NULL
Pathology	NULL
,	NULL
Vienna	NULL
,	NULL
Austria	NULL
;	NULL
the	NULL
Children	NULL
's	NULL
Cancer	NULL
Research	NULL
Institute	NULL
,	NULL
St.	NULL
Anna	NULL
Kinderspital	NULL
,	NULL
Vienna	NULL
,	NULL
Austria	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Laboratory	NULL
Medicine	NULL
,	NULL
Donauspital	NULL
SMZ-Ost	NULL
,	NULL
Vienna	NULL
,	NULL
Austria	NULL
.	NULL

Submitted	NULL
December	NULL
2	NULL
,	NULL
1998	NULL
;	NULL
accepted	NULL
March	NULL
22	NULL
,	NULL
1999	NULL
.	NULL

Supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Forschungsforderungsfund	NULL
fiir	NULL
die	NULL
Gewerbliche	NULL
Wirtschaft	NULL
(	NULL
FFF3/10628	NULL
)	NULL
,	NULL
the	NULL
Dutch	NULL
Cancer	NULL
Society	NULL
(	NULL
EUR	NULL
95-1021	NULL
)	NULL
,	NULL
and	NULL
the	NULL
European	NULL
Community	NULL
(	NULL
Biomed	NULL
2-PL951355	NULL
)	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Marieke	NULL
von	NULL
Lindern	NULL
,	NULL
PhD	NULL
,	NULL
Institute	NULL
of	NULL
Hematology	NULL
,	NULL
Erasmus	NULL
University	NULL
,	NULL
p/o	NULL
Box	NULL
1738	NULL
,	NULL
3000	NULL
DR	NULL
Rotterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
;	NULL
e-mail	NULL
:	NULL
vonlindern	NULL
@	NULL
hema.fgg.eurnl	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/99/9402-00408	NULL
$	NULL
3.00/0	NULL
550	NULL
to	NULL
a	NULL
10°-	NULL
to	NULL
10	NULL
``	NULL
-fold	NULL
amplification	NULL
of	NULL
erythroid	NULL
cells	NULL
.	NULL

Dex	NULL
acted	NULL
directly	NULL
on	NULL
erythroid	NULL
progenitors	NULL
and	NULL
maintained	NULL
the	NULL
colony-forming	NULL
capacity	NULL
of	NULL
the	NULL
progenitor	NULL
cells	NULL
expanded	NULL
in	NULL
liquid	NULL
cultures	NULL
.	NULL

The	NULL
hormone	NULL
delayed	NULL
terminal	NULL
differentiation	NULL
into	NULL
erythrocytes	NULL
,	NULL
which	NULL
was	NULL
assayed	NULL
by	NULL
morphology	NULL
,	NULL
hemoglobin	NULL
accumulation	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
characteristic	NULL
for	NULL
immature	NULL
cells	NULL
.	NULL

Sustained	NULL
proliferation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
could	NULL
be	NULL
induced	NULL
equally	NULL
well	NULL
from	NULL
purified	NULL
erythroid	NULL
burst-forming	NULL
units	NULL
(	NULL
BFU-E	NULL
)	NULL
,	NULL
from	NULL
CD34+	NULL
blast	NULL
cells	NULL
,	NULL
and	NULL
from	NULL
bone	NULL
marrow	NULL
depleted	NULL
from	NULL
CD34+	NULL
cells	NULL
.	NULL

©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

resemble	NULL
leukemic	NULL
cells	NULL
transformed	NULL
by	NULL
v-ErbA	NULL
and	NULL
v-ErbB	NULL
as	NULL
regards	NULL
their	NULL
abilities	NULL
to	NULL
proliferate	NULL
without	NULL
differentiation	NULL
for	NULL
25	NULL
to	NULL
30	NULL
generations	NULL
.	NULL

*8	NULL
This	NULL
progress	NULL
in	NULL
identifying	NULL
the	NULL
players	NULL
that	NULL
regulate	NULL
the	NULL
balance	NULL
between	NULL
proliferation	NULL
and	NULL
differentiation	NULL
in	NULL
normal	NULL
avian	NULL
erythropoiesis	NULL
prompted	NULL
us	NULL
to	NULL
study	NULL
whether	NULL
similar	NULL
mechanisms	NULL
operate	NULL
in	NULL
human	NULL
erythropoiesis	NULL
.	NULL

If	NULL
a	NULL
similar	NULL
synergism	NULL
between	NULL
tyrosine	NULL
kinase	NULL
receptors	NULL
and	NULL
steroid	NULL
hormones	NULL
would	NULL
apply	NULL
to	NULL
human	NULL
erythropoiesis	NULL
,	NULL
it	NULL
may	NULL
be	NULL
possible	NULL
to	NULL
establish	NULL
mass	NULL
cultures	NULL
of	NULL
human	NULL
erythroid	NULL
progenitors	NULL
through	NULL
the	NULL
addition	NULL
of	NULL
recombinant	NULL
factors	NULL
and	NULL
hormones	NULL
that	NULL
would	NULL
selectively	NULL
provoke	NULL
proliferation	NULL
and	NULL
yield	NULL
cell	NULL
numbers	NULL
large	NULL
enough	NULL
to	NULL
perform	NULL
biochemical	NULL
and	NULL
molecular	NULL
studies	NULL
.	NULL

In	NULL
mammals	NULL
,	NULL
erythropoietin	NULL
(	NULL
Epo	NULL
)	NULL
and	NULL
SCF	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
crucial	NULL
factors	NULL
in	NULL
erythropoiesis	NULL
.	NULL

Mice	NULL
with	NULL
a	NULL
homozygous	NULL
disruption	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
Epo	NULL
or	NULL
the	NULL
Epo-receptor	NULL
(	NULL
EpoR	NULL
)	NULL
die	NULL
at	NULL
day	NULL
13.5	NULL
of	NULL
gestation	NULL
due	NULL
to	NULL
a	NULL
lack	NULL
of	NULL
erythrocytes	NULL
.	NULL
``	NULL

Erythroid	NULL
burst-forming	NULL
units	NULL
(	NULL
BFU-E	NULL
)	NULL
and	NULL
erythroid	NULL
colony-forming	NULL
units	NULL
(	NULL
CFU-E	NULL
)	NULL
can	NULL
be	NULL
isolated	NULL
from	NULL
the	NULL
fetal	NULL
liver	NULL
of	NULL
these	NULL
mice	NULL
,	NULL
but	NULL
cells	NULL
lacking	NULL
the	NULL
EpoR	NULL
can	NULL
not	NULL
mature	NULL
to	NULL
erythrocytes	NULL
.	NULL
``	NULL

Mice	NULL
that	NULL
lack	NULL
SCF	NULL
or	NULL
c-Kit	NULL
,	NULL
its	NULL
receptor	NULL
,	NULL
suffer	NULL
from	NULL
severe	NULL
anemia	NULL
.	NULL
``	NULL

c-Kit	NULL
is	NULL
expressed	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
of	NULL
the	NULL
earliest	NULL
progenitor	NULL
up	NULL
to	NULL
the	NULL
stage	NULL
of	NULL
the	NULL
basophilic	NULL
erythroblast	NULL
.	NULL
``	NULL

''	NULL
In	NULL
the	NULL
presence	NULL
of	NULL
SCF	NULL
,	NULL
erythroid	NULL
progenitors	NULL
undergo	NULL
an	NULL
increased	NULL
number	NULL
of	NULL
cell	NULL
divisions	NULL
before	NULL
they	NULL
develop	NULL
into	NULL
mature	NULL
erythrocytes	NULL
.	NULL

!	NULL

+	NULL
``	NULL
5	NULL
The	NULL
role	NULL
of	NULL
steroids	NULL
in	NULL
mammalian	NULL
erythropoiesis	NULL
has	NULL
remained	NULL
elusive	NULL
.	NULL

In	NULL
macrophages	NULL
and	NULL
lymphocytes	NULL
,	NULL
glucocorticoids	NULL
induce	NULL
apoptosis	NULL
due	NULL
to	NULL
inhibition	NULL
of	NULL
API	NULL
and	NULL
NFB	NULL
transcription	NULL
complexes	NULL
.	NULL
``	NULL

However	NULL
,	NULL
glucocorticoids	NULL
were	NULL
shown	NULL
to	NULL
increase	NULL
the	NULL
number	NULL
of	NULL
erythroid	NULL
colonies	NULL
grown	NULL
in	NULL
vitro	NULL
from	NULL
normal	NULL
bone	NULL
marrow	NULL
,	NULL
``	NULL
and	NULL
treatment	NULL
of	NULL
nonanemic	NULL
patients	NULL
with	NULL
the	NULL
synthetic	NULL
glucocorticoid	NULL
receptor	NULL
(	NULL
GR	NULL
)	NULL
ligand	NULL
prednisone	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
enhance	NULL
erythropoiesis	NULL
.	NULL
``	NULL

''	NULL
Thus	NULL
,	NULL
the	NULL
GR	NULL
may	NULL
have	NULL
a	NULL
stimulatory	NULL
role	NULL
in	NULL
mammalian	NULL
erythropoiesis	NULL
similar	NULL
to	NULL
what	NULL
was	NULL
found	NULL
in	NULL
avian	NULL
erythroid	NULL
progenitors	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
GR	NULL
ligand	NULL
dexamethasone	NULL
(	NULL
Dex	NULL
)	NULL
to	NULL
Epo	NULL
and	NULL
SCF	NULL
allowed	NULL
the	NULL
establishment	NULL
of	NULL
mass	NULL
cultures	NULL
of	NULL
normal	NULL
erythroid	NULL
progenitors	NULL
from	NULL
mononuclear	NULL
cells	NULL
of	NULL
human	NULL
umbilical	NULL
cord	NULL
blood	NULL
,	NULL
bone	NULL
marrow	NULL
,	NULL
and	NULL
peripheral	NULL
blood	NULL
.	NULL

Erythroid	NULL
cells	NULL
in	NULL
these	NULL
mass	NULL
Blood	NULL
,	NULL
Vol	NULL
94	NULL
,	NULL
No	NULL
2	NULL
(	NULL
July	NULL
15	NULL
)	NULL
,	NULL
1999	NULL
;	NULL
pp	NULL
550-559	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CORTICOSTEROIDS	NULL
ENHANCE	NULL
ERYTHROID	NULL
PROLIFERATION	NULL
cultures	NULL
underwent	NULL
15	NULL
to	NULL
20	NULL
cell	NULL
divisions	NULL
.	NULL

Cultures	NULL
of	NULL
purified	NULL
BFU-E	NULL
,	NULL
as	NULL
well	NULL
as	NULL
CD34*	NULL
and	NULL
even	NULL
CD34~	NULL
cells	NULL
could	NULL
be	NULL
expanded	NULL
up	NULL
to	NULL
10	NULL
%	NULL
-fold	NULL
.	NULL

Morphologically	NULL
,	NULL
95	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
culture	NULL
appeared	NULL
as	NULL
proerythroblasts	NULL
,	NULL
which	NULL
could	NULL
be	NULL
induced	NULL
to	NULL
terminal	NULL
erythroid	NULL
differentiation	NULL
upon	NULL
removal	NULL
of	NULL
SCF	NULL
and	NULL
Dex	NULL
.	NULL

Single-cell	NULL
cloning	NULL
experiments	NULL
suggested	NULL
that	NULL
Dex	NULL
acts	NULL
directly	NULL
on	NULL
human	NULL
erythroid	NULL
progenitors	NULL
,	NULL
maintaining	NULL
their	NULL
colony-forming	NULL
capacity	NULL
and	NULL
delaying	NULL
their	NULL
differentiation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
and	NULL
cell	NULL
culture	NULL
.	NULL

-	NULL
Neonatal	NULL
cord	NULL
blood	NULL
,	NULL
bone	NULL
marrow	NULL
,	NULL
or	NULL
buffy	NULL
coat	NULL
from	NULL
peripheral	NULL
blood	NULL
was	NULL
obtained	NULL
from	NULL
healthy	NULL
volunteers	NULL
after	NULL
informed	NULL
consent	NULL
was	NULL
received	NULL
.	NULL

Mononuclear	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
centrifugation	NULL
over	NULL
a	NULL
Ficoll	NULL
gradient	NULL
and	NULL
seeded	NULL
in	NULL
CFU-E	NULL
medium	NULL
as	NULL
described	NULL
,	NULL
``	NULL
with	NULL
minor	NULL
modifications	NULL
:	NULL
conalbumin	NULL
was	NULL
replaced	NULL
by	NULL
human	NULL
transferrin	NULL
(	NULL
iron-loaded	NULL
;	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
chicken	NULL
serum	NULL
was	NULL
omitted	NULL
and	NULL
only	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
12	NULL
%	NULL
;	NULL
GIBCO	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
was	NULL
used	NULL
.	NULL

Unless	NULL
mentioned	NULL
otherwise	NULL
,	NULL
we	NULL
used	NULL
0.5	NULL
U/mL	NULL
recombinant	NULL
human	NULL
Epo	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Janssen-Cilag	NULL
,	NULL
Tilburg	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
,	NULL
100	NULL
ng/mL	NULL
recombinant	NULL
human	NULL
SCF	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Amgen	NULL
[	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
]	NULL
or	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
[	NULL
Minneapolis	NULL
,	NULL
MNJ	NULL
)	NULL
,	NULL
40	NULL
ng/mL	NULL
recombinant	NULL
human	NULL
insulin-like	NULL
growth	NULL
factor-I	NULL
(	NULL
IGF-I	NULL
;	NULL
R	NULL
&	NULL
D	NULL
)	NULL
,	NULL
1	NULL
U/mL	NULL
human	NULL
insulin	NULL
(	NULL
Actrapid	NULL
;	NULL
40	NULL
IU/mL	NULL
;	NULL
Bayer-Leverkusen	NULL
,	NULL
Leverkusen	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
5	NULL
X	NULL
10~	NULL
``	NULL
mol/L	NULL
Dex	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
5	NULL
X	NULL
10~	NULL
``	NULL
mol/L	NULL
Dex-antagonist	NULL
ZK112,993	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Schering	NULL
,	NULL
Madison	NULL
,	NULL
NJ	NULL
)	NULL
;	NULL
obtained	NULL
through	NULL
Dr	NULL
E.	NULL
Miillner	NULL
,	NULL
Biocenter	NULL
,	NULL
Vienna	NULL
,	NULL
Austria	NULL
)	NULL
.	NULL

In	NULL
initial	NULL
experiments	NULL
,	NULL
CD34*	NULL
cells	NULL
were	NULL
purified	NULL
from	NULL
cord	NULL
blood	NULL
on	NULL
CellPro	NULL
columns	NULL
.	NULL

For	NULL
the	NULL
separation	NULL
of	NULL
CD34	NULL
*	NULL
cells	NULL
from	NULL
bone	NULL
marrow	NULL
,	NULL
Minimacs	NULL
columns	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Bergisch	NULL
Gladbach	NULL
,	NULL
Germany	NULL
)	NULL
were	NULL
used	NULL
.	NULL

Total	NULL
mononuclear	NULL
cells	NULL
were	NULL
initially	NULL
plated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
10	NULL
X	NULL
10°	NULL
cells/mL	NULL
.	NULL

During	NULL
the	NULL
first	NULL
5	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
cell	NULL
density	NULL
was	NULL
reduced	NULL
to	NULL
1	NULL
to	NULL
2	NULL
X	NULL
10	NULL
%	NULL
/mL	NULL
.	NULL

Small	NULL
mature	NULL
cells	NULL
and	NULL
apoptotic	NULL
cells	NULL
were	NULL
removed	NULL
once	NULL
or	NULL
twice	NULL
during	NULL
the	NULL
first	NULL
week	NULL
of	NULL
the	NULL
culture	NULL
by	NULL
centrifugation	NULL
through	NULL
Percoll	NULL
step-gradients	NULL
(	NULL
density	NULL
,	NULL
1.075	NULL
g/mL	NULL
;	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Such	NULL
a	NULL
purification	NULL
was	NULL
always	NULL
performed	NULL
when	NULL
cultures	NULL
were	NULL
started	NULL
from	NULL
mononuclear	NULL
cells	NULL
derived	NULL
from	NULL
buffy	NULL
coat	NULL
or	NULL
cord	NULL
blood	NULL
;	NULL
they	NULL
could	NULL
be	NULL
omitted	NULL
for	NULL
bone	NULL
marrow	NULL
cultures	NULL
.	NULL

Cells	NULL
were	NULL
kept	NULL
at	NULL
1	NULL
to	NULL
2	NULL
X	NULL
10°	NULL
through	NULL
daily	NULL
dilutions	NULL
or	NULL
medium	NULL
changes	NULL
with	NULL
fresh	NULL
medium	NULL
containing	NULL
factors	NULL
.	NULL

Cells	NULL
were	NULL
counted	NULL
on	NULL
an	NULL
electronic	NULL
cell	NULL
counter	NULL
(	NULL
CASY-1	NULL
;	NULL
Schirfe-System	NULL
,	NULL
Reutlingen	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Fluorescence-activated	NULL
cell	NULL
sorting	NULL
(	NULL
FACS	NULL
)	NULL
analysis	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
using	NULL
directly	NULL
labeled	NULL
antibodies	NULL
against	NULL
human	NULL
cell	NULL
surface	NULL
markers	NULL
(	NULL
DAKO	NULL
[	NULL
Vienna	NULL
,	NULL
Austria	NULL
]	NULL
and	NULL
Serotec	NULL
[	NULL
Vienna	NULL
,	NULL
Austria	NULL
)	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
directions	NULL
.	NULL

Analysis	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Propidium	NULL
iodide-positive	NULL
cells	NULL
were	NULL
excluded	NULL
from	NULL
analysis	NULL
.	NULL

To	NULL
sort	NULL
BFU-E	NULL
and	NULL
blast	NULL
cells	NULL
,	NULL
100	NULL
X	NULL
10°	NULL
frozen	NULL
mononuclear	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
thawed	NULL
and	NULL
CD34*	NULL
cells	NULL
were	NULL
purified	NULL
using	NULL
a	NULL
MACS	NULL
CD34	NULL
isolation	NULL
kit	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
)	NULL
according	NULL
to	NULL
the	NULL
guidelines	NULL
of	NULL
the	NULL
supplier	NULL
.	NULL

The	NULL
CD34~	NULL
fraction	NULL
was	NULL
labeled	NULL
with	NULL
CD34-Texas	NULL
Red	NULL
(	NULL
TR	NULL
)	NULL
,	NULL
and	NULL
the	NULL
CD34	NULL
*	NULL
fraction	NULL
was	NULL
labeled	NULL
with	NULL
CD34-TR	NULL
,	NULL
CD38-phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
,	NULL
and	NULL
CD71	NULL
-fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
in	NULL
one	NULL
incubation	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
and	NULL
resuspended	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
plus	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
sorted	NULL
using	NULL
a	NULL
FACS-Vantage	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

After	NULL
sorting	NULL
,	NULL
cell	NULL
samples	NULL
were	NULL
counted	NULL
,	NULL
centrifuged	NULL
on	NULL
slides	NULL
,	NULL
and	NULL
seeded	NULL
in	NULL
human	NULL
CFU-E	NULL
medium	NULL
with	NULL
factors	NULL
as	NULL
described	NULL
.	NULL

The	NULL
initial	NULL
cell	NULL
numbers	NULL
in	NULL
Fig	NULL
6	NULL
are	NULL
recalculated	NULL
to	NULL
the	NULL
total	NULL
number	NULL
of	NULL
cells	NULL
obtained	NULL
after	NULL
sorting	NULL
.	NULL

Determination	NULL
of	NULL
hemoglobin	NULL
accumulation	NULL
and	NULL
cell	NULL
morphology	NULL
.	NULL

To	NULL
determine	NULL
hemoglobin	NULL
accumulation	NULL
,	NULL
3	NULL
X	NULL
50	NULL
uL	NULL
aliquots	NULL
of	NULL
the	NULL
cultures	NULL
were	NULL
removed	NULL
and	NULL
processed	NULL
for	NULL
photometric	NULL
determination	NULL
of	NULL
hemoglobin	NULL
.	NULL

**	NULL
To	NULL
analyze	NULL
cell	NULL
morphology	NULL
,	NULL
cells	NULL
were	NULL
cytocentrifuged	NULL
onto	NULL
slides	NULL
and	NULL
stained	NULL
with	NULL
histological	NULL
dyes	NULL
and	NULL
neutral	NULL
benzidine	NULL
for	NULL
551	NULL
hemoglobin	NULL
.	NULL

``	NULL
?	NULL

Images	NULL
were	NULL
taken	NULL
using	NULL
a	NULL
CCD	NULL
camera	NULL
(	NULL
Photometrics	NULL
,	NULL
Tucson	NULL
,	NULL
AZ	NULL
)	NULL
and	NULL
a	NULL
blue	NULL
filter	NULL
(	NULL
480	NULL
nm	NULL
)	NULL
,	NULL
so	NULL
that	NULL
mature	NULL
cells	NULL
(	NULL
stained	NULL
yellow	NULL
to	NULL
brownish	NULL
)	NULL
appear	NULL
darkly	NULL
stained	NULL
.	NULL

Images	NULL
were	NULL
processed	NULL
with	NULL
Adobe	NULL
Photoshop	NULL
(	NULL
Adobe	NULL
Systems	NULL
Inc	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Colony	NULL
assays	NULL
.	NULL

-	NULL
To	NULL
determine	NULL
the	NULL
number	NULL
of	NULL
colony-forming	NULL
cells	NULL
and	NULL
their	NULL
expansion	NULL
potential	NULL
,	NULL
Ficoll-purified	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
CFU-E	NULL
medium	NULL
and	NULL
subsequently	NULL
seeded	NULL
at	NULL
the	NULL
indicated	NULL
cell	NULL
numbers	NULL
per	NULL
well	NULL
in	NULL
96-well	NULL
plates	NULL
,	NULL
using	NULL
CFU-E	NULL
medium	NULL
complemented	NULL
with	NULL
1	NULL
mg/mL	NULL
fibrinogen	NULL
and	NULL
0.1	NULL
U/mL	NULL
thrombin	NULL
immediately	NULL
before	NULL
aliquoting	NULL
50	NULL
uL	NULL
of	NULL
cell	NULL
suspension	NULL
per	NULL
well	NULL
.	NULL

After	NULL
coagulation	NULL
,	NULL
another	NULL
50	NULL
uL	NULL
of	NULL
medium	NULL
was	NULL
added	NULL
containing	NULL
combinations	NULL
of	NULL
factors	NULL
at	NULL
double	NULL
the	NULL
concentrations	NULL
indicated	NULL
above	NULL
.	NULL

Every	NULL
second	NULL
day	NULL
,	NULL
the	NULL
medium	NULL
above	NULL
the	NULL
clot	NULL
was	NULL
replaced	NULL
by	NULL
fresh	NULL
medium	NULL
with	NULL
factors	NULL
.	NULL

To	NULL
determine	NULL
hemoglobinization	NULL
of	NULL
the	NULL
colonies	NULL
,	NULL
10	NULL
uL	NULL
acid	NULL
benzidine	NULL
staining	NULL
solution	NULL
(	NULL
a	NULL
freshly	NULL
prepared	NULL
mix	NULL
of	NULL
150	NULL
uL	NULL
10	NULL
%	NULL
acetic	NULL
acid	NULL
,	NULL
20	NULL
uL	NULL
3	NULL
%	NULL
free	NULL
benzidine	NULL
base	NULL
in	NULL
acetic	NULL
acid	NULL
,	NULL
and	NULL
10	NULL
uL	NULL
30	NULL
%	NULL
H	NULL
;	NULL
O	NULL
;	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
medium	NULL
above	NULL
the	NULL
clots	NULL
.	NULL

Northern	NULL
blot	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
from	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
using	NULL
the	NULL
method	NULL
of	NULL
Chomezynski	NULL
and	NULL
Sacchi	NULL
``	NULL
with	NULL
minor	NULL
modifica-tions	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
GITC	NULL
buffer	NULL
and	NULL
NaAc	NULL
,	NULL
pH4.0	NULL
,	NULL
was	NULL
added	NULL
to	NULL
25	NULL
mmol/L	NULL
.	NULL

The	NULL
solution	NULL
was	NULL
extracted	NULL
with	NULL
H	NULL
,	NULL
O-saturated	NULL
phenol	NULL
plus	NULL
chloroform	NULL
and	NULL
isoamylalcohol	NULL
.	NULL

RNA	NULL
was	NULL
precipitated	NULL
with	NULL
isopropa-nol	NULL
and	NULL
dissolved	NULL
in	NULL
10	NULL
mmol/L	NULL
Tris	NULL
,	NULL
pH	NULL
7	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.2	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
.	NULL

Proteinase	NULL
K	NULL
was	NULL
added	NULL
to	NULL
200	NULL
ug/mL	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
37°C	NULL
.	NULL

RNA	NULL
was	NULL
extracted	NULL
with	NULL
phenol	NULL
:	NULL
chloroform	NULL
:	NULL
isoamylalcohol	NULL
(	NULL
25:24:1	NULL
)	NULL
pH	NULL
7	NULL
and	NULL
precipitated	NULL
with	NULL
ethanol	NULL
.	NULL

Ten	NULL
to	NULL
20	NULL
ug	NULL
of	NULL
RNA	NULL
was	NULL
run	NULL
on	NULL
a	NULL
formaldehyde-containing	NULL
agarose	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
nylon	NULL
filters	NULL
(	NULL
Gene	NULL
Screen	NULL
;	NULL
Gene	NULL
Vest	NULL
Inc	NULL
,	NULL
Toronto	NULL
,	NULL
Canada	NULL
)	NULL
using	NULL
conventional	NULL
procedures	NULL
.	NULL
``	NULL

''	NULL
Probes	NULL
used	NULL
were	NULL
the	NULL
entire	NULL
ORF	NULL
of	NULL
human	NULL
GATA-1	NULL
,	NULL
c-myb	NULL
,	NULL
c-Kit	NULL
,	NULL
or	NULL
RBTN2/TTG-2	NULL
.	NULL

Phosphotyrosine	NULL
blot	NULL
.	NULL

-	NULL
Cultured	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
and	NULL
incubated	NULL
in	NULL
medium	NULL
without	NULL
growth	NULL
factors	NULL
for	NULL
12	NULL
hours	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
,	NULL
suspended	NULL
in	NULL
medium	NULL
,	NULL
and	NULL
treated	NULL
10	NULL
minutes	NULL
at	NULL
37°C	NULL
with	NULL
either	NULL
10	NULL
U/mL	NULL
rhEpo	NULL
,	NULL
1	NULL
ug/mL	NULL
SCF	NULL
,	NULL
400	NULL
ng/mL	NULL
IGF-I	NULL
,	NULL
100	NULL
ng/mL	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
,	NULL
100	NULL
ng/mL	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
or	NULL
100	NULL
ng/mL	NULL
insulin	NULL
.	NULL

Cells	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
lysed	NULL
in	NULL
20	NULL
uL	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
50	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
100	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
10	NULL
ug/mL	NULL
aprotinin	NULL
,	NULL
and	NULL
2	NULL
ug/mL	NULL
leupeptin	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
for	NULL
15	NULL
minutes	NULL
at	NULL
15,000	NULL
rpm	NULL
before	NULL
use	NULL
.	NULL

Lysates	NULL
derived	NULL
from	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
run	NULL
on	NULL
a	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
(	NULL
DuPont	NULL
,	NULL
Wilmington	NULL
,	NULL
DE	NULL
)	NULL
.	NULL

The	NULL
Western	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
the	NULL
antiphosphotyrosine	NULL
antibody	NULL
4G10	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

RESULTS	NULL
Sustained	NULL
proliferation	NULL
of	NULL
immature	NULL
human	NULL
erythroid	NULL
progenitors	NULL
.	NULL

-	NULL
CD34-selected	NULL
cells	NULL
or	NULL
the	NULL
total	NULL
fraction	NULL
of	NULL
mononuclear	NULL
cells	NULL
derived	NULL
from	NULL
human	NULL
cord	NULL
blood	NULL
were	NULL
seeded	NULL
in	NULL
CFU-E	NULL
medium	NULL
supplemented	NULL
with	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
TGFa	NULL
,	NULL
estradiol	NULL
,	NULL
and	NULL
Dex	NULL
.	NULL

After	NULL
a	NULL
lag-phase	NULL
of	NULL
6	NULL
days	NULL
,	NULL
cell	NULL
numbers	NULL
started	NULL
to	NULL
increase	NULL
,	NULL
with	NULL
a	NULL
doubling	NULL
time	NULL
of	NULL
20	NULL
to	NULL
24	NULL
hours	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
105-fold	NULL
increase	NULL
over	NULL
a	NULL
14-day	NULL
period	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

Cell	NULL
samples	NULL
were	NULL
taken	NULL
from	NULL
the	NULL
cultures	NULL
at	NULL
subsequent	NULL
days	NULL
,	NULL
and	NULL
cytologi-cal	NULL
analysis	NULL
showed	NULL
typical	NULL
erythroblasts	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
maturation	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

After	NULL
18	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
both	NULL
the	NULL
growth	NULL
rate	NULL
and	NULL
the	NULL
fraction	NULL
of	NULL
cells	NULL
with	NULL
a	NULL
proerythroblast	NULL
morphology	NULL
decreased	NULL
,	NULL
whereas	NULL
the	NULL
number	NULL
of	NULL
partially	NULL
mature	NULL
erythroid	NULL
cells	NULL
increased	NULL
(	NULL
Fig	NULL
1B	NULL
,	NULL
panels	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

When	NULL
cells	NULL
were	NULL
harvested	NULL
from	NULL
the	NULL
culture	NULL
,	NULL
separated	NULL
by	NULL
Percoll	NULL
,	NULL
and	NULL
reseeded	NULL
in	NULL
secondary	NULL
cultures	NULL
,	NULL
the	NULL
growth	NULL
rate	NULL
of	NULL
the	NULL
cultures	NULL
was	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

552	NULL
VON	NULL
LINDERN	NULL
ET	NULL
AL	NULL
O	NULL
bone	NULL
marrow	NULL
10°	NULL
1	NULL
unpurified	NULL
104	NULL
+	NULL
15	NULL
!	NULL

Percoll	NULL
pur	NULL
.	NULL

200	NULL
Percoll	NULL
pur	NULL
.	NULL

10°	NULL
+	NULL
o	NULL
p	NULL
O	NULL
M	NULL
3	NULL
``	NULL
d	NULL
Percoll	NULL
pur	NULL
.	NULL

1010	NULL
|	NULL
10°	NULL
|	NULL
tm	NULL
total	NULL
cell	NULL
number	NULL
To	NULL
0	NULL
5	NULL
10	NULL
15	NULL
20	NULL
25	NULL
days	NULL
in	NULL
culture	NULL
total	NULL
cell	NULL
number	NULL
3	NULL
1	NULL
10	NULL
``	NULL
s	NULL
EJ	NULL
10°	NULL
;	NULL
r	NULL
E	NULL
~-	NULL
0	NULL
5	NULL
10	NULL
15	NULL
peripheral	NULL
blood	NULL
10°	NULL
a	NULL
``	NULL
_	NULL
total	NULL
cell	NULL
number	NULL
tn	NULL
&	NULL
in	NULL
days	NULL
in	NULL
culture	NULL
Fig	NULL
1	NULL
.	NULL

Outgrowth	NULL
of	NULL
erythroid	NULL
progenitors	NULL
from	NULL
neonatal	NULL
cord	NULL
blood	NULL
,	NULL
human	NULL
bone	NULL
marrow	NULL
,	NULL
or	NULL
peripheral	NULL
blood	NULL
.	NULL

(	NULL
A	NULL
)	NULL
CD34+	NULL
cells	NULL
isolated	NULL
from	NULL
neonatal	NULL
cord	NULL
blood	NULL
were	NULL
cultured	NULL
in	NULL
CFU-E	NULL
medium	NULL
complemented	NULL
w	NULL
ith	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
IGF-I	NULL
,	NULL
and	NULL
Dex	NULL
(	NULL
lower	NULL
part	NULL
)	NULL
.	NULL

Cell	NULL
density	NULL
was	NULL
kept	NULL
at	NULL
1.5	NULL
to	NULL
3	NULL
x	NULL
108	NULL
cells/	NULL
mL	NULL
and	NULL
total	NULL
cell	NULL
numbers	NULL
were	NULL
enumerated	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

At	NULL
day	NULL
14	NULL
(	NULL
arrowhead	NULL
)	NULL
,	NULL
immature	NULL
low-density	NULL
cells	NULL
were	NULL
purified	NULL
from	NULL
the	NULL
mass	NULL
culture	NULL
using	NULL
Percoll	NULL
1.072	NULL
g/mL	NULL
and	NULL
reseeded	NULL
(	NULL
top	NULL
part	NULL
)	NULL
.	NULL

This	NULL
procedure	NULL
was	NULL
repeated	NULL
several	NULL
times	NULL
.	NULL

(	NULL
B	NULL
)	NULL
At	NULL
day	NULL
8	NULL
(	NULL
1	NULL
)	NULL
,	NULL
day	NULL
12	NULL
(	NULL
2	NULL
)	NULL
,	NULL
and	NULL
day	NULL
17	NULL
(	NULL
3	NULL
)	NULL
after	NULL
initiating	NULL
the	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
cytocentrifuged	NULL
onto	NULL
slides	NULL
and	NULL
stained	NULL
with	NULL
histochemical	NULL
dyes	NULL
plus	NULL
a	NULL
specific	NULL
stain	NULL
for	NULL
hemoglobin	NULL
that	NULL
makes	NULL
hemoglobinized	NULL
cells	NULL
appear	NULL
dark	NULL
in	NULL
this	NULL
figure	NULL
.	NULL
``	NULL

''	NULL
Numbers	NULL
of	NULL
panels	NULL
correspond	NULL
to	NULL
numbered	NULL
arrows	NULL
in	NULL
(	NULL
A	NULL
)	NULL
,	NULL
indicating	NULL
the	NULL
time	NULL
of	NULL
aliquot	NULL
removal	NULL
.	NULL

(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
Ficoll-purified	NULL
cells	NULL
from	NULL
bone	NULL
marrow	NULL
(	NULL
3	NULL
healthy	NULL
donors	NULL
)	NULL
or	NULL
from	NULL
peripheral	NULL
blood	NULL
(	NULL
5	NULL
untreated	NULL
,	NULL
healthy	NULL
donors	NULL
)	NULL
were	NULL
cultivated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
(	NULL
A	NULL
)	NULL
and	NULL
cumulative	NULL
cell	NULL
numbers	NULL
were	NULL
calculated	NULL
.	NULL

In	NULL
case	NULL
of	NULL
the	NULL
peripheral	NULL
blood-derived	NULL
cells	NULL
,	NULL
apoptotic	NULL
cells	NULL
and	NULL
lymphocytes	NULL
were	NULL
removed	NULL
by	NULL
centrifugation	NULL
through	NULL
Percoll	NULL
1.072	NULL
g/mL	NULL
at	NULL
days	NULL
4	NULL
and	NULL
6	NULL
of	NULL
culture	NULL
.	NULL

reestablished	NULL
using	NULL
the	NULL
low-density	NULL
cell	NULL
fraction	NULL
containing	NULL
immature	NULL
erythroblasts	NULL
.	NULL

Rapid	NULL
growth	NULL
could	NULL
be	NULL
repetitively	NULL
restored	NULL
by	NULL
successive	NULL
rounds	NULL
of	NULL
purification	NULL
(	NULL
Fig	NULL
1A	NULL
,	NULL
top	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
indicated	NULL
that	NULL
immature	NULL
progenitors	NULL
recoverable	NULL
from	NULL
the	NULL
culture	NULL
had	NULL
retained	NULL
the	NULL
capacity	NULL
to	NULL
proliferate	NULL
(	NULL
a	NULL
10-fold	NULL
expansion	NULL
equivalent	NULL
to	NULL
~20	NULL
population	NULL
doublings	NULL
)	NULL
.	NULL

Cultures	NULL
of	NULL
human	NULL
bone	NULL
marrow	NULL
or	NULL
mononuclear	NULL
cells	NULL
derived	NULL
from	NULL
peripheral	NULL
blood	NULL
showed	NULL
very	NULL
similar	NULL
expansion	NULL
kinetics	NULL
under	NULL
the	NULL
same	NULL
culture	NULL
conditions	NULL
(	NULL
Fig	NULL
1C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
more	NULL
accurately	NULL
the	NULL
in	NULL
vitro	NULL
life	NULL
span	NULL
of	NULL
human	NULL
erythroid	NULL
progenitors	NULL
proliferating	NULL
in	NULL
these	NULL
cultures	NULL
,	NULL
mononuclear	NULL
cells	NULL
from	NULL
cord	NULL
blood	NULL
were	NULL
seeded	NULL
into	NULL
the	NULL
above	NULL
medium	NULL
under	NULL
limiting	NULL
dilution	NULL
conditions	NULL
.	NULL
``	NULL

''	NULL
Cells	NULL
from	NULL
wells	NULL
containing	NULL
one	NULL
single	NULL
colony	NULL
only	NULL
were	NULL
expanded	NULL
until	NULL
extinc-tion	NULL
.	NULL

During	NULL
propagation	NULL
,	NULL
cell	NULL
numbers	NULL
were	NULL
counted	NULL
and	NULL
total	NULL
cell	NULL
numbers	NULL
were	NULL
enumerated	NULL
.	NULL

From	NULL
more	NULL
than	NULL
80	NULL
%	NULL
of	NULL
these	NULL
single	NULL
colonies	NULL
between	NULL
1	NULL
X	NULL
10°	NULL
and	NULL
4	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
generated	NULL
,	NULL
which	NULL
is	NULL
equivalent	NULL
to	NULL
an	NULL
average	NULL
amplification	NULL
of	NULL
16	NULL
to	NULL
22	NULL
generations	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
cells	NULL
grown	NULL
in	NULL
cultures	NULL
supplemented	NULL
with	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
Dex	NULL
.	NULL

-	NULL
FACS	NULL
analysis	NULL
of	NULL
the	NULL
cells	NULL
grown	NULL
in	NULL
cultures	NULL
supplemented	NULL
with	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
Dex	NULL
showed	NULL
that	NULL
most	NULL
of	NULL
the	NULL
cells	NULL
expressed	NULL
an	NULL
immature	NULL
phenotype	NULL
(	NULL
80	NULL
%	NULL
to	NULL
95	NULL
%	NULL
CD71+*	NULL
and	NULL
50	NULL
%	NULL
to	NULL
80	NULL
%	NULL
CD117+*	NULL
cells	NULL
)	NULL
.	NULL

Approximately	NULL
20	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
maturing	NULL
erythroid	NULL
cells	NULL
(	NULL
CD36*	NULL
and	NULL
GPA*	NULL
)	NULL
and	NULL
5	NULL
%	NULL
to	NULL
7	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
of	NULL
the	NULL
myeloid	NULL
or	NULL
lymphoid	NULL
lineage	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Cells	NULL
lacked	NULL
CD34	NULL
expression	NULL
,	NULL
even	NULL
when	NULL
stained	NULL
at	NULL
only	NULL
5	NULL
days	NULL
of	NULL
culture	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
cells	NULL
from	NULL
several	NULL
independent	NULL
cultures	NULL
were	NULL
tested	NULL
in	NULL
colony	NULL
assays	NULL
.	NULL

Cells	NULL
taken	NULL
from	NULL
13-	NULL
or	NULL
15-day-old	NULL
cultures	NULL
of	NULL
cord	NULL
blood	NULL
formed	NULL
predominantly	NULL
erythroid	NULL
bursts	NULL
and	NULL
only	NULL
a	NULL
very	NULL
small	NULL
number	NULL
of	NULL
myeloid	NULL
colonies	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
expansion	NULL
of	NULL
cultures	NULL
obtained	NULL
from	NULL
mononuclear	NULL
cells	NULL
of	NULL
neonatal	NULL
cord	NULL
blood	NULL
or	NULL
bone	NULL
marrow	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
Dex	NULL
is	NULL
mainly	NULL
the	NULL
result	NULL
of	NULL
proliferation	NULL
of	NULL
erythroid	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
the	NULL
cultured	NULL
cells	NULL
were	NULL
responsive	NULL
to	NULL
distinct	NULL
factors	NULL
in	NULL
short-term	NULL
proliferation	NULL
assays	NULL
(	NULL
incor-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CORTICOSTEROIDS	NULL
ENHANCE	NULL
ERYTHROID	NULL
PROLIFERATION	NULL
Table	NULL
1	NULL
.	NULL

FACS	NULL
Analysis	NULL
of	NULL
Cultures	NULL
Grow	NULL
n	NULL
From	NULL
Mononuclear	NULL
Cells	NULL
Derived	NULL
From	NULL
Neonatal	NULL
Cord	NULL
Blood	NULL
Percentage	NULL
of	NULL
Positive	NULL
Cells	NULL
9-Day	NULL
15-Day	NULL
Cell	NULL
Surface	NULL
Marker	NULL
Culture	NULL
Culture	NULL
(	NULL
Erythroid	NULL
)	NULL
blasts	NULL
CD71	NULL
Transferrin	NULL
receptor	NULL
95	NULL
80	NULL
CD117	NULL
c-KIT	NULL
80	NULL
50	NULL
Erythroid	NULL
CD36/GPA	NULL
gp	NULL
V/glycophorin	NULL
A	NULL
20	NULL
21	NULL
Nonerythroid	NULL
CD13	NULL
Aminopeptidase	NULL
N	NULL
5	NULL
<	NULL
1	NULL
CD14	NULL
LPS	NULL
receptor	NULL
5	NULL
<	NULL
1	NULL
CD89	NULL
Fo	NULL
?	NULL

-receptor	NULL
3	NULL
<	NULL
1	NULL
CD33	NULL
Monocyte	NULL
marker	NULL
7	NULL
CD3	NULL
T-cell	NULL
receptor	NULL
<	NULL
0.1	NULL
CD19	NULL
B4-protein	NULL
<	NULL
0.1	NULL
All	NULL
FACS	NULL
analysis	NULL
were	NULL
performed	NULL
twice	NULL
on	NULL
independently	NULL
derived	NULL
cultures	NULL
.	NULL

poration	NULL
of	NULL
tritiated	NULL
thymidine	NULL
)	NULL
and	NULL
in	NULL
a	NULL
biochemical	NULL
assay	NULL
(	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
incorporated	NULL
tritiated	NULL
thymidine	NULL
in	NULL
response	NULL
to	NULL
Epo	NULL
.	NULL

SCF	NULL
and	NULL
IGF-I	NULL
did	NULL
not	NULL
induce	NULL
DNA	NULL
synthesis	NULL
if	NULL
added	NULL
alone	NULL
,	NULL
but	NULL
they	NULL
enhanced	NULL
the	NULL
incorporation	NULL
of	NULL
tritiated	NULL
thymidine	NULL
when	NULL
added	NULL
together	NULL
with	NULL
a	NULL
suboptimal	NULL
concentration	NULL
of	NULL
Epo	NULL
.	NULL

The	NULL
cells	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
TGFa	NULL
or	NULL
other	NULL
epidermal	NULL
growth	NULL
factor	NULL
(	NULL
EGF	NULL
)	NULL
-like	NULL
ligands	NULL
,	NULL
IL-3	NULL
or	NULL
GM-CSF	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
erythroid	NULL
proliferation	NULL
factors	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
IGF-I	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
multiple	NULL
substrate	NULL
proteins	NULL
,	NULL
as	NULL
detected	NULL
with	NULL
antiphosphotyrosine	NULL
antibodies	NULL
in	NULL
a	NULL
Western	NULL
blot	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

No	NULL
phosphorylation	NULL
of	NULL
substrates	NULL
was	NULL
detected	NULL
when	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-3	NULL
,	NULL
GM-CSF	NULL
,	NULL
or	NULL
EGF-like	NULL
substrates	NULL
(	NULL
Fig	NULL
2	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
cultures	NULL
established	NULL
from	NULL
bone	NULL
marrow	NULL
or	NULL
cord	NULL
blood	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
Dex	NULL
consisted	NULL
of	NULL
90	NULL
%	NULL
to	NULL
95	NULL
%	NULL
erythroid	NULL
progenitors	NULL
.	NULL

In	NULL
the	NULL
following	NULL
,	NULL
we	NULL
used	NULL
these	NULL
cultures	NULL
to	NULL
determine	NULL
how	NULL
corticosteroids	NULL
contribute	NULL
to	NULL
the	NULL
in	NULL
vitro	NULL
expansion	NULL
of	NULL
erythroid	NULL
progenitors	NULL
.	NULL

Human	NULL
erythroid	NULL
progenitors	NULL
require	NULL
glucocorticosteroids	NULL
for	NULL
sustained	NULL
proliferation	NULL
.	NULL

-	NULL
In	NULL
all	NULL
avian	NULL
erythroid	NULL
progenitors	NULL
,	NULL
the	NULL
GR	NULL
ligand	NULL
Dex	NULL
was	NULL
indispensable	NULL
for	NULL
progenitor	NULL
self-renewal	NULL
.	NULL
``	NULL

However	NULL
,	NULL
the	NULL
major	NULL
role	NULL
of	NULL
Dex	NULL
in	NULL
the	NULL
outgrowth	NULL
of	NULL
erythroid	NULL
progenitors	NULL
from	NULL
human	NULL
bone	NULL
marrow	NULL
mononuclear	NULL
cells	NULL
could	NULL
still	NULL
be	NULL
mediated	NULL
by	NULL
nonerythroid	NULL
accessory	NULL
cells	NULL
.	NULL

Human	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
either	NULL
Dex	NULL
or	NULL
the	NULL
GR-antagonist	NULL
ZK	NULL
.	NULL

Amplification	NULL
of	NULL
erythroid	NULL
progenitors	NULL
from	NULL
bone	NULL
marrow	NULL
cells	NULL
of	NULL
several	NULL
independent	NULL
donors	NULL
was	NULL
at	NULL
least	NULL
10-fold	NULL
reduced	NULL
after	NULL
culture	NULL
for	NULL
10	NULL
days	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ZK	NULL
as	NULL
compared	NULL
with	NULL
cultures	NULL
supplemented	NULL
with	NULL
Dex	NULL
(	NULL
Fig	NULL
3A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
the	NULL
GR-antagonist	NULL
ZK	NULL
was	NULL
required	NULL
to	NULL
unveil	NULL
the	NULL
effect	NULL
of	NULL
Dex	NULL
,	NULL
due	NULL
Table	NULL
2	NULL
.	NULL

Colonies	NULL
Derived	NULL
From	NULL
13-	NULL
or	NULL
16-Day	NULL
Cultures	NULL
of	NULL
Neonatal	NULL
Cord	NULL
Blood	NULL
Colony	NULL
Type	NULL
Per	NULL
10	NULL
``	NULL
Cells	NULL
Seeded	NULL
Erythroid/	NULL
BFU-E	NULL
Myeloid	NULL
Mixed	NULL
CFU-GM	NULL
13-day	NULL
culture	NULL
5,750	NULL
400	NULL
200	NULL
15-day	NULL
culture	NULL
2,500	NULL
105	NULL
100	NULL
553	NULL
a	NULL
§	NULL
<	NULL
|	NULL
9	NULL
o	NULL
2	NULL
a	NULL
7T	NULL
=	NULL
.	NULL

a	NULL
a	NULL
£9	NULL
2	NULL
0	NULL
ere	NULL
<	NULL
-	NULL
195	NULL
-	NULL
.	NULL

%	NULL
he	NULL
w-	NULL
'	NULL
4	NULL
«	NULL
<	NULL
-	NULL
112	NULL
``	NULL
e	NULL
<	NULL
-	NULL
84	NULL
at	NULL
--	NULL
«	NULL
<	NULL
-	NULL
63	NULL
..	NULL
``	NULL
<	NULL
—	NULL
52	NULL
rt	NULL
``	NULL
``	NULL
<	NULL
-	NULL
36	NULL
<	NULL
-	NULL
26	NULL
Fig	NULL
2	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
induced	NULL
by	NULL
activation	NULL
of	NULL
receptors	NULL
for	NULL
growth	NULL
factors	NULL
and	NULL
cytokines	NULL
.	NULL

Erythroid	NULL
progenitors	NULL
were	NULL
withdraw	NULL
n	NULL
from	NULL
growth	NULL
factors	NULL
overnight	NULL
and	NULL
subsequently	NULL
stimulated	NULL
for	NULL
10	NULL
minutes	NULL
with	NULL
the	NULL
cytokines	NULL
indicated	NULL
,	NULL
using	NULL
10-fold	NULL
higher	NULL
concentrations	NULL
than	NULL
used	NULL
in	NULL
liquid	NULL
cultures	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
separated	NULL
on	NULL
acrylamide	NULL
gels	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
the	NULL
antiphosphotyrosine	NULL
antibody	NULL
4G10	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
the	NULL
size	NULL
markers	NULL
used	NULL
.	NULL

to	NULL
the	NULL
presence	NULL
of	NULL
corticosteroids	NULL
in	NULL
serum	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
Dex	NULL
or	NULL
ZK	NULL
,	NULL
the	NULL
proliferation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
depends	NULL
very	NULL
much	NULL
on	NULL
the	NULL
serum	NULL
batch	NULL
used	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
corticosteroids	NULL
,	NULL
as	NULL
a	NULL
major	NULL
factor	NULL
required	NULL
for	NULL
the	NULL
proliferation	NULL
of	NULL
avian	NULL
erythroid	NULL
progenitors	NULL
,	NULL
are	NULL
removed	NULL
from	NULL
serum	NULL
by	NULL
freon/charcoal	NULL
treatment	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
ZK112,993	NULL
to	NULL
serum	NULL
had	NULL
the	NULL
same	NULL
effect	NULL
.	NULL
``	NULL

Subsequently	NULL
,	NULL
the	NULL
colony-forming	NULL
capacity	NULL
of	NULL
aliquots	NULL
from	NULL
the	NULL
same	NULL
cultures	NULL
was	NULL
determined	NULL
at	NULL
successive	NULL
intervals	NULL
,	NULL
using	NULL
a	NULL
limiting	NULL
dilution	NULL
approach	NULL
.	NULL

Bone	NULL
marrow	NULL
cells	NULL
were	NULL
seeded	NULL
in	NULL
fibrinogen	NULL
clots	NULL
at	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
15	NULL
cells	NULL
per	NULL
well	NULL
in	NULL
96-well	NULL
plates	NULL
.	NULL

The	NULL
cells	NULL
,	NULL
grown	NULL
in	NULL
liquid	NULL
cultures	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
Dex	NULL
or	NULL
ZK	NULL
,	NULL
were	NULL
exposed	NULL
to	NULL
Epo	NULL
,	NULL
IGF-I	NULL
,	NULL
and	NULL
SCF	NULL
and	NULL
from	NULL
each	NULL
culture	NULL
again	NULL
to	NULL
Dex	NULL
and	NULL
ZK	NULL
.	NULL

Benzidine-positive	NULL
colonies	NULL
were	NULL
scored	NULL
after	NULL
10	NULL
days	NULL
as	NULL
small	NULL
(	NULL
4	NULL
to	NULL
30	NULL
)	NULL
,	NULL
medium	NULL
(	NULL
30	NULL
to	NULL
100	NULL
)	NULL
,	NULL
or	NULL
large	NULL
(	NULL
>	NULL
100	NULL
cells	NULL
)	NULL
.	NULL

At	NULL
the	NULL
start	NULL
of	NULL
the	NULL
culture	NULL
(	NULL
day	NULL
0	NULL
)	NULL
,	NULL
a	NULL
similar	NULL
number	NULL
of	NULL
colonies	NULL
was	NULL
obtained	NULL
(	NULL
~1.5	NULL
%	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
Dex	NULL
or	NULL
ZK	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ZK	NULL
,	NULL
the	NULL
colonies	NULL
were	NULL
smaller	NULL
and	NULL
more	NULL
hemoglobinized	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
.	NULL

In	NULL
liquid	NULL
cultures	NULL
containing	NULL
Dex	NULL
,	NULL
the	NULL
number	NULL
of	NULL
erythroid	NULL
colony-forming	NULL
units	NULL
(	NULL
ECFU	NULL
)	NULL
had	NULL
increased	NULL
20-fold	NULL
in	NULL
4	NULL
days	NULL
and	NULL
100-fold	NULL
in	NULL
8	NULL
days	NULL
,	NULL
with	NULL
50	NULL
%	NULL
of	NULL
these	NULL
ECFU	NULL
able	NULL
to	NULL
undergo	NULL
at	NULL
least	NULL
another	NULL
5	NULL
cell	NULL
divisions	NULL
(	NULL
colony	NULL
size	NULL
,	NULL
>	NULL
30	NULL
cells	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
bone	NULL
marrow	NULL
cultures	NULL
in	NULL
presence	NULL
of	NULL
the	NULL
GR-antagonist	NULL
ZK	NULL
resulted	NULL
only	NULL
in	NULL
a	NULL
10-fold	NULL
increase	NULL
of	NULL
ECFC	NULL
after	NULL
4	NULL
days	NULL
and	NULL
no	NULL
further	NULL
amplification	NULL
at	NULL
8	NULL
days	NULL
of	NULL
culture	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
.	NULL

Irrespective	NULL
of	NULL
the	NULL
conditions	NULL
of	NULL
liquid	NULL
culture	NULL
,	NULL
fibrinogen	NULL
clots	NULL
containing	NULL
Dex	NULL
yielded	NULL
colonies	NULL
that	NULL
were	NULL
larger	NULL
and	NULL
less	NULL
hemoglobinized	NULL
and	NULL
that	NULL
exceeded	NULL
4	NULL
to	NULL
5	NULL
times	NULL
in	NULL
colony	NULL
number	NULL
compared	NULL
with	NULL
fibrinogen	NULL
clots	NULL
containing	NULL
ZK	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
colonies	NULL
per	NULL
100	NULL
cells	NULL
seeded	NULL
was	NULL
constant	NULL
under	NULL
all	NULL
conditions	NULL
,	NULL
regardless	NULL
of	NULL
whether	NULL
15	NULL
,	NULL
5	NULL
,	NULL
or	NULL
2	NULL
cells	NULL
had	NULL
been	NULL
seeded	NULL
per	NULL
well	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
Dex	NULL
supports	NULL
sustained	NULL
proliferation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
and	NULL
that	NULL
it	NULL
acts	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

554	NULL
VON	NULL
LINDERN	NULL
ET	NULL
AL	NULL
A	NULL
B	NULL
200	NULL
1	NULL
colony	NULL
size	NULL
4	NULL
32	NULL
[	NULL
C	NULL
]	NULL
>	NULL
100	NULL
cells	NULL
L	NULL
,	NULL
102	NULL
e	NULL
c	NULL
,	NULL
67	NULL
50	NULL
ES	NULL
30	NULL
-	NULL
100	NULL
cells	NULL
x	NULL
-	NULL
#	NULL
-	NULL
e	NULL
.9	NULL
w	NULL
g	NULL
iso	NULL
+	NULL
2	NULL
-+-	NULL
DEX	NULL
3	NULL
2	NULL
E	NULL
<	NULL
30	NULL
cells	NULL
3	NULL
o	NULL
a	NULL
Z	NULL
108	NULL
an	NULL
&	NULL
a	NULL
8G	NULL
100	NULL
2	NULL
ES	NULL
§	NULL
in	NULL
25	NULL
10	NULL
C	NULL
2	NULL
2	NULL
%	NULL
5o	NULL
!	NULL

led	NULL
6	NULL
106	NULL
o	NULL
|	NULL
0	NULL
5	NULL
10	NULL
15	NULL
20	NULL
.	NULL

Dex	NULL
-	NULL
ZK	NULL
Dex	NULL
-	NULL
ZK	NULL
days	NULL
in	NULL
culture	NULL
day	NULL
0	NULL
day	NULL
4	NULL
day	NULL
8	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Dex	NULL
enhances	NULL
proliferation	NULL
and	NULL
colony-forming	NULL
ability	NULL
of	NULL
erythroid	NULL
progenitors	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Human	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
complemented	NULL
with	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
IGF-1	NULL
,	NULL
and	NULL
either	NULL
Dex	NULL
or	NULL
ZK	NULL
(	NULL
C	NULL
and	NULL
M	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
At	NULL
days	NULL
0	NULL
,	NULL
4	NULL
,	NULL
and	NULL
8	NULL
,	NULL
cell	NULL
aliquots	NULL
of	NULL
both	NULL
cultures	NULL
were	NULL
seeded	NULL
in	NULL
fibrinogen	NULL
clots	NULL
w	NULL
ith	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
15	NULL
cells	NULL
per	NULL
well	NULL
and	NULL
medium	NULL
complemented	NULL
with	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
IGF-1	NULL
,	NULL
and	NULL
either	NULL
Dex	NULL
or	NULL
ZK	NULL
(	NULL
indicated	NULL
by	NULL
D	NULL
or	NULL
Z	NULL
at	NULL
the	NULL
X-axis	NULL
)	NULL
was	NULL
added	NULL
.	NULL

Previous	NULL
liquid	NULL
culture	NULL
conditions	NULL
are	NULL
indicated	NULL
below	NULL
by	NULL
Dex	NULL
or	NULL
ZK	NULL
.	NULL

After	NULL
10	NULL
days	NULL
,	NULL
colonies	NULL
were	NULL
stained	NULL
with	NULL
benzidine	NULL
and	NULL
counted	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
number	NULL
per	NULL
colony	NULL
was	NULL
estimated	NULL
as	NULL
small	NULL
(	NULL
0	NULL
to	NULL
30	NULL
cells	NULL
)	NULL
,	NULL
medium	NULL
(	NULL
30	NULL
to	NULL
100	NULL
cells	NULL
)	NULL
,	NULL
or	NULL
large	NULL
(	NULL
>	NULL
100	NULL
cells	NULL
)	NULL
.	NULL

Colony	NULL
number	NULL
is	NULL
given	NULL
per	NULL
100	NULL
bone	NULL
marrow	NULL
cells	NULL
seeded	NULL
in	NULL
the	NULL
culture	NULL
at	NULL
day	NULL
0	NULL
.	NULL

The	NULL
number	NULL
above	NULL
the	NULL
bars	NULL
indicates	NULL
the	NULL
percentage	NULL
of	NULL
only	NULL
partially	NULL
hemoglobinized	NULL
colonies	NULL
.	NULL

directly	NULL
on	NULL
these	NULL
progenitors	NULL
.	NULL

Dex	NULL
increased	NULL
both	NULL
the	NULL
number	NULL
of	NULL
colony-forming	NULL
cells	NULL
in	NULL
the	NULL
mass	NULL
cultures	NULL
and	NULL
the	NULL
proportion	NULL
of	NULL
immature	NULL
colonies	NULL
derived	NULL
from	NULL
these	NULL
colony-forming	NULL
cells	NULL
.	NULL

The	NULL
ability	NULL
to	NULL
form	NULL
medium-sized	NULL
to	NULL
large	NULL
colonies	NULL
in	NULL
Dex	NULL
did	NULL
not	NULL
change	NULL
largely	NULL
in	NULL
the	NULL
Dex-treated	NULL
mass	NULL
cultures	NULL
,	NULL
but	NULL
rapidly	NULL
decreased	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ZK	NULL
.	NULL

Cooperation	NULL
of	NULL
the	NULL
GR	NULL
with	NULL
the	NULL
EpoR	NULL
and	NULL
c-Kit	NULL
arrests	NULL
human	NULL
proerythroblast	NULL
differentiation	NULL
and	NULL
maintains	NULL
the	NULL
expression	NULL
of	NULL
immature	NULL
erythroblast	NULL
markers	NULL
.	NULL

We	NULL
next	NULL
tested	NULL
in	NULL
more	NULL
detail	NULL
how	NULL
Dex	NULL
affects	NULL
the	NULL
balance	NULL
of	NULL
proliferation	NULL
and	NULL
differentiation	NULL
in	NULL
an	NULL
established	NULL
culture	NULL
of	NULL
erythroid	NULL
progenitors	NULL
.	NULL

Aliquots	NULL
from	NULL
a	NULL
6-day-old	NULL
culture	NULL
of	NULL
erythroid	NULL
progenitors	NULL
were	NULL
seeded	NULL
in	NULL
media	NULL
containing	NULL
Epo	NULL
,	NULL
IGF-I	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
either	NULL
Dex	NULL
or	NULL
the	NULL
GR-antagonist	NULL
ZK	NULL
.	NULL

Cell	NULL
numbers	NULL
were	NULL
counted	NULL
daily	NULL
and	NULL
aliquots	NULL
were	NULL
processed	NULL
to	NULL
determine	NULL
hemoglobin	NULL
content	NULL
and	NULL
morphology	NULL
.	NULL

Three	NULL
days	NULL
after	NULL
applying	NULL
the	NULL
different	NULL
conditions	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
,	NULL
cultures	NULL
containing	NULL
ZK	NULL
became	NULL
stationary	NULL
,	NULL
whereas	NULL
cultures	NULL
containing	NULL
Dex	NULL
continued	NULL
to	NULL
proliferate	NULL
.	NULL

Concurrently	NULL
,	NULL
hemoglobin	NULL
levels	NULL
increased	NULL
considerably	NULL
in	NULL
cells	NULL
grown	NULL
in	NULL
ZK-containing	NULL
medium	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

Cytospins	NULL
showed	NULL
that	NULL
cultures	NULL
exposed	NULL
to	NULL
ZK	NULL
differentiated	NULL
completely	NULL
into	NULL
small	NULL
,	NULL
partially	NULL
enucleated	NULL
erythrocyte-like	NULL
cells	NULL
and	NULL
then	NULL
disintegrated	NULL
(	NULL
Fig	NULL
4C	NULL
,	NULL
bottom	NULL
panels	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cultures	NULL
kept	NULL
in	NULL
Dex	NULL
retained	NULL
their	NULL
low	NULL
hemoglobin	NULL
content	NULL
,	NULL
large	NULL
size	NULL
,	NULL
and	NULL
basophilic	NULL
erythroblast	NULL
morphology	NULL
throughout	NULL
the	NULL
experiment	NULL
(	NULL
Fig	NULL
4C	NULL
,	NULL
top	NULL
panels	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
Epo	NULL
,	NULL
the	NULL
cells	NULL
neither	NULL
proliferated	NULL
nor	NULL
differentiated	NULL
irrespective	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
Dex	NULL
,	NULL
ZK	NULL
,	NULL
or	NULL
SCF	NULL
,	NULL
whereas	NULL
the	NULL
presence	NULL
of	NULL
Epo	NULL
but	NULL
not	NULL
SCF	NULL
resulted	NULL
in	NULL
rapid	NULL
differentiation	NULL
,	NULL
as	NULL
shown	NULL
elsewhere	NULL
for	NULL
human	NULL
cells	NULL
``	NULL
``	NULL
as	NULL
well	NULL
as	NULL
for	NULL
avian	NULL
progenitors	NULL
.	NULL
``	NULL

''	NULL
The	NULL
presence	NULL
of	NULL
Dex	NULL
or	NULL
ZK	NULL
did	NULL
not	NULL
affect	NULL
Epo-induced	NULL
differentiation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
which	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
observations	NULL
in	NULL
avian	NULL
cells	NULL
in	NULL
which	NULL
Dex	NULL
cooperates	NULL
with	NULL
SCF	NULL
to	NULL
retain	NULL
erythroid	NULL
cells	NULL
in	NULL
an	NULL
immature	NULL
state	NULL
.	NULL
``	NULL

Earlier	NULL
work	NULL
in	NULL
the	NULL
chicken	NULL
had	NULL
shown	NULL
that	NULL
Dex	NULL
maintained	NULL
the	NULL
expression	NULL
of	NULL
c-myb	NULL
,	NULL
which	NULL
is	NULL
a	NULL
requirement	NULL
for	NULL
long-term	NULL
proliferation	NULL
.	NULL
``	NULL

Self-renewing	NULL
avian	NULL
erythroblasts	NULL
also	NULL
express	NULL
c-Kit	NULL
.	NULL

Upon	NULL
induction	NULL
of	NULL
differentiation	NULL
,	NULL
c-myb	NULL
and	NULL
c-Kit	NULL
are	NULL
rapidly	NULL
downregulated	NULL
.	NULL

RBTN2	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
selectively	NULL
expressed	NULL
in	NULL
immature	NULL
erythroid	NULL
cells	NULL
(	NULL
M.v.L	NULL
.	NULL

,	NULL
unpublished	NULL
data	NULL
)	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
progression	NULL
past	NULL
the	NULL
proerythroblast	NULL
stage	NULL
according	NULL
to	NULL
observations	NULL
in	NULL
RBTN2	NULL
-/-	NULL
mice	NULL
.	NULL
``	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
GATA-1	NULL
is	NULL
required	NULL
during	NULL
terminal	NULL
differentiation	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
We	NULL
examined	NULL
whether	NULL
Dex	NULL
affects	NULL
transcription	NULL
of	NULL
c-myb	NULL
,	NULL
c-Kit	NULL
,	NULL
RBTN2	NULL
,	NULL
and	NULL
GATA-1	NULL
in	NULL
human	NULL
erythroid	NULL
progenitors	NULL
.	NULL

Aliquots	NULL
from	NULL
a	NULL
10-day-old	NULL
culture	NULL
were	NULL
kept	NULL
for	NULL
48	NULL
hours	NULL
in	NULL
medium	NULL
containing	NULL
charcoal-stripped	NULL
serum	NULL
and	NULL
growth	NULL
factors	NULL
,	NULL
but	NULL
no	NULL
steroid	NULL
hormones	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
GR	NULL
agonist	NULL
Dex	NULL
or	NULL
antagonist	NULL
ZK	NULL
were	NULL
added	NULL
,	NULL
and	NULL
cell	NULL
samples	NULL
were	NULL
processed	NULL
daily	NULL
for	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

mRNA	NULL
levels	NULL
of	NULL
c-myb	NULL
,	NULL
c-Kit	NULL
,	NULL
and	NULL
RBTN2	NULL
increased	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Dex	NULL
,	NULL
whereas	NULL
they	NULL
remained	NULL
low	NULL
or	NULL
declined	NULL
in	NULL
ZK	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
levels	NULL
of	NULL
GATA-1	NULL
were	NULL
not	NULL
affected	NULL
by	NULL
activation	NULL
or	NULL
inactivation	NULL
of	NULL
the	NULL
GR	NULL
.	NULL

The	NULL
apparent	NULL
upregulation	NULL
of	NULL
c-myb	NULL
,	NULL
c-Kit	NULL
,	NULL
and	NULL
RBTN2	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
Dex	NULL
stimulates	NULL
sustained	NULL
proliferation	NULL
of	NULL
immature	NULL
erythroid	NULL
cells	NULL
and	NULL
delays	NULL
differentiation	NULL
.	NULL

Origin	NULL
of	NULL
erythroid	NULL
progenitors	NULL
capable	NULL
of	NULL
sustained	NULL
cell	NULL
proliferation	NULL
.	NULL

-	NULL
We	NULL
then	NULL
set	NULL
out	NULL
to	NULL
characterize	NULL
the	NULL
progenitor	NULL
cell	NULL
phenotype	NULL
that	NULL
was	NULL
responsive	NULL
to	NULL
stimulation	NULL
of	NULL
expansion	NULL
by	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
Dex	NULL
.	NULL

Human	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
separated	NULL
into	NULL
CD34+*	NULL
and	NULL
CD34~T	NULL
fractions	NULL
.	NULL

The	NULL
CD34~	NULL
fraction	NULL
was	NULL
subjected	NULL
twice	NULL
to	NULL
depletion	NULL
of	NULL
CD34*	NULL
cells	NULL
and	NULL
finally	NULL
contained	NULL
less	NULL
than	NULL
0.1	NULL
%	NULL
CD34*	NULL
cells	NULL
by	NULL
FACS	NULL
analysis	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

The	NULL
CD34*	NULL
cells	NULL
were	NULL
stained	NULL
for	NULL
CD34	NULL
,	NULL
CD71	NULL
,	NULL
and	NULL
CD38	NULL
and	NULL
were	NULL
sorted	NULL
by	NULL
FACS	NULL
into	NULL
two	NULL
subfractions	NULL
:	NULL
a	NULL
blast	NULL
fraction	NULL
(	NULL
CD34*	NULL
,	NULL
low	NULL
CD71	NULL
,	NULL
low	NULL
CD38	NULL
;	NULL
gate	NULL
R3	NULL
,	NULL
Fig	NULL
6C	NULL
)	NULL
and	NULL
a	NULL
BFU-E-enriched	NULL
fraction	NULL
(	NULL
CD34*	NULL
,	NULL
high	NULL
CD71	NULL
;	NULL
gate	NULL
R4	NULL
,	NULL
Fig	NULL
6C	NULL
)	NULL
.	NULL

After	NULL
purification	NULL
,	NULL
the	NULL
three	NULL
subpopulations	NULL
(	NULL
blast	NULL
cells	NULL
,	NULL
BFU-E	NULL
fraction	NULL
,	NULL
and	NULL
CD34~	NULL
cells	NULL
)	NULL
were	NULL
seeded	NULL
in	NULL
medium	NULL
containing	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
Dex	NULL
,	NULL
and	NULL
proliferation	NULL
was	NULL
monitored	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CORTICOSTEROIDS	NULL
ENHANCE	NULL
ERYTHROID	NULL
PROLIFERATION	NULL
555	NULL
Proliferation	NULL
Differentiation	NULL
a	NULL
25	NULL
{	NULL
a	NULL
109	NULL
-	NULL
é	NULL
E	NULL
2	NULL
2	NULL
E	NULL
\	NULL
2	NULL
ao8	NULL
|	NULL
G	NULL
3	NULL
10	NULL
$	NULL
Ep	NULL
15	NULL
3	NULL
T	NULL
E	NULL
[	NULL
=	NULL
10	NULL
``	NULL
4	NULL
10	NULL
|	NULL
-	NULL
<	NULL
SD	NULL
a	NULL
5	NULL
|	NULL
10°	NULL
|	NULL
R	NULL
?	NULL
'	NULL

m	NULL
0	NULL
+	NULL
+	NULL
:	NULL
0	NULL
5	NULL
10	NULL
15	NULL
5	NULL
10	NULL
15	NULL
days	NULL
in	NULL
culture	NULL
O	NULL
day	NULL
8	NULL
£26	NULL
e	NULL
,	NULL
0	NULL
Fig	NULL
4	NULL
.	NULL

Dex	NULL
supports	NULL
proliferation	NULL
and	NULL
inhibits	NULL
differentiation	NULL
.	NULL

Cells	NULL
from	NULL
a	NULL
culture	NULL
of	NULL
neonatal	NULL
cord	NULL
blood	NULL
cells	NULL
were	NULL
washed	NULL
5	NULL
days	NULL
after	NULL
seeding	NULL
and	NULL
aliquots	NULL
exposed	NULL
to	NULL
medium	NULL
plus	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
Dex	NULL
(	NULL
@	NULL
)	NULL
or	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
the	NULL
GR-antagonist	NULL
ZK	NULL
112,993	NULL
(	NULL
M	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Proliferation	NULL
was	NULL
monitored	NULL
by	NULL
calculating	NULL
cumulative	NULL
cell	NULL
numbers	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Hemoglobin	NULL
accumulation	NULL
was	NULL
deter-	NULL
D	NULL
Dexamethasone	NULL
``	NULL
©	NULL
Dexamethasone	NULL
days	NULL
in	NULL
culture	NULL
H	NULL
zK	NULL
112,993	NULL
mined	NULL
at	NULL
the	NULL
days	NULL
indicated	NULL
and	NULL
plotted	NULL
as	NULL
milligrams	NULL
of	NULL
hemoglobin	NULL
per	NULL
10°	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
)	NULL
At	NULL
the	NULL
days	NULL
indicated	NULL
by	NULL
arrows	NULL
in	NULL
(	NULL
A	NULL
)	NULL
,	NULL
cell	NULL
samples	NULL
from	NULL
cultures	NULL
containing	NULL
Dex	NULL
(	NULL
upper	NULL
panels	NULL
)	NULL
or	NULL
ZK	NULL
112,993	NULL
(	NULL
lower	NULL
panels	NULL
)	NULL
were	NULL
cytocentrifuged	NULL
onto	NULL
slides	NULL
and	NULL
stained	NULL
cytochemically	NULL
with	NULL
a	NULL
specific	NULL
stain	NULL
for	NULL
hemoglobin	NULL
.	NULL

a	NULL
ZK	NULL
112,993	NULL
Well-hemoglobinized	NULL
cells	NULL
show	NULL
nds	NULL
a	NULL
dark	NULL
to	NULL
black	NULL
cytoplasm	NULL
.	NULL

&	NULL
by	NULL
daily	NULL
counting	NULL
(	NULL
Fig	NULL
6D	NULL
)	NULL
.	NULL

Approximately	NULL
equal	NULL
numbers	NULL
of	NULL
erythroid	NULL
progenitors	NULL
could	NULL
be	NULL
grown	NULL
from	NULL
all	NULL
three	NULL
cell	NULL
populations	NULL
,	NULL
which	NULL
corresponded	NULL
with	NULL
an	NULL
expansion	NULL
of	NULL
10°-fold	NULL
for	NULL
the	NULL
purified	NULL
BFU-E	NULL
fraction	NULL
(	NULL
Fig	NULL
6D	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cultures	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
cell	NULL
numbers	NULL
reached	NULL
a	NULL
plateau	NULL
at	NULL
approximately	NULL
15	NULL
days	NULL
when	NULL
the	NULL
cells	NULL
started	NULL
to	NULL
mature	NULL
to	NULL
hemoglobinized	NULL
cells	NULL
.	NULL

All	NULL
cultures	NULL
contained	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
erythroid	NULL
progenitors	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
cytocentrifugation	NULL
and	NULL
benzidine	NULL
staining	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
cultures	NULL
of	NULL
committed	NULL
erythroid	NULL
progenitors	NULL
can	NULL
be	NULL
established	NULL
from	NULL
cells	NULL
of	NULL
varying	NULL
maturity	NULL
(	NULL
including	NULL
CD34~	NULL
erythroid	NULL
progenitors	NULL
,	NULL
generally	NULL
considered	NULL
as	NULL
[	NULL
post-JCFU-E	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
glucocorticoids	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
sustained	NULL
proliferation	NULL
of	NULL
human	NULL
erythroid	NULL
progenitors	NULL
can	NULL
be	NULL
induced	NULL
upon	NULL
activation	NULL
of	NULL
EpoR	NULL
,	NULL
c-Kit	NULL
,	NULL
and	NULL
GR	NULL
by	NULL
their	NULL
respective	NULL
ligands	NULL
.	NULL

Mass	NULL
cultures	NULL
yielding	NULL
10°	NULL
to	NULL
10	NULL
erythroid	NULL
cells	NULL
were	NULL
established	NULL
from	NULL
a	NULL
few	NULL
million	NULL
mononuclear	NULL
cells	NULL
derived	NULL
from	NULL
umbilical	NULL
cord	NULL
blood	NULL
,	NULL
bone	NULL
marrow	NULL
,	NULL
or	NULL
peripheral	NULL
blood	NULL
.	NULL

The	NULL
cultures	NULL
differed	NULL
from	NULL
previously	NULL
described	NULL
cultures	NULL
of	NULL
erythroid	NULL
progenitors	NULL
by	NULL
their	NULL
dependence	NULL
on	NULL
GR-ligands	NULL
.	NULL

These	NULL
ligands	NULL
were	NULL
shown	NULL
to	NULL
exert	NULL
their	NULL
effect	NULL
directly	NULL
on	NULL
the	NULL
erythroid	NULL
progenitors	NULL
,	NULL
and	NULL
they	NULL
maintained	NULL
the	NULL
colony-forming	NULL
ability	NULL
of	NULL
the	NULL
progenitors	NULL
expanded	NULL
in	NULL
liquid	NULL
culture	NULL
while	NULL
suppressing	NULL
their	NULL
differentiation	NULL
.	NULL

The	NULL
cultures	NULL
consisted	NULL
of	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
pure	NULL
erythroid	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

556	NULL
dO	NULL
-	NULL
dl	NULL
d2	NULL
-	NULL
d3	NULL
+-	NULL
Dexamethasone	NULL
|	NULL
ZK112,993	NULL
c-Myb	NULL
e	NULL
~.-.|	NULL
c-Kit	NULL
*	NULL
~C	NULL
@	NULL
-	NULL
®	NULL
+	NULL
+	NULL
+	NULL
|	NULL
|	NULL
RBTN2	NULL
Gata-1	NULL
Fig	NULL
5	NULL
.	NULL

Dex	NULL
maintains	NULL
high	NULL
expression	NULL
levels	NULL
of	NULL
c-myb	NULL
,	NULL
c-Kit	NULL
,	NULL
and	NULL
RBTN2	NULL
.	NULL

A	NULL
culture	NULL
of	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
was	NULL
kept	NULL
for	NULL
2	NULL
days	NULL
in	NULL
medium	NULL
containing	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
IGF-I	NULL
,	NULL
and	NULL
freon/charcoal	NULL
stripped	NULL
serum	NULL
(	NULL
depleted	NULL
from	NULL
Dex	NULL
)	NULL
.	NULL

Thereafter	NULL
,	NULL
aliquots	NULL
of	NULL
the	NULL
culture	NULL
were	NULL
cultivated	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
supplemented	NULL
with	NULL
either	NULL
Dex	NULL
or	NULL
ZK	NULL
112,993	NULL
at	NULL
10-®	NULL
mol/L	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
untreated	NULL
cells	NULL
(	NULL
day	NULL
0	NULL
)	NULL
or	NULL
from	NULL
cells	NULL
cultured	NULL
for	NULL
1	NULL
,	NULL
2	NULL
,	NULL
or	NULL
3	NULL
days	NULL
in	NULL
GR	NULL
agonist	NULL
or	NULL
antagonist	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
analyzed	NULL
on	NULL
Northern	NULL
blots	NULL
,	NULL
using	NULL
full-length	NULL
c-DNA	NULL
probes	NULL
of	NULL
c-myb	NULL
,	NULL
c-Kit	NULL
,	NULL
RBTN2	NULL
,	NULL
and	NULL
GATA-1	NULL
.	NULL

The	NULL
ethidium	NULL
staining	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
bottom	NULL
panel	NULL
as	NULL
a	NULL
loading	NULL
control	NULL
.	NULL

progenitors	NULL
,	NULL
apparent	NULL
mainly	NULL
as	NULL
proerythroblasts	NULL
and	NULL
basophilic	NULL
erythroblasts	NULL
and	NULL
able	NULL
to	NULL
undergo	NULL
approximately	NULL
15	NULL
to	NULL
20	NULL
generations	NULL
in	NULL
culture	NULL
.	NULL

These	NULL
cultures	NULL
of	NULL
proliferating	NULL
human	NULL
erythroblasts	NULL
could	NULL
be	NULL
obtained	NULL
from	NULL
both	NULL
CD34*	NULL
and	NULL
CD34~	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
from	NULL
a	NULL
cell	NULL
fraction	NULL
enriched	NULL
for	NULL
BFU-E	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
expansion	NULL
capacity	NULL
of	NULL
human	NULL
erythroid	NULL
progenitors	NULL
,	NULL
like	NULL
their	NULL
counterparts	NULL
in	NULL
chicken	NULL
and	NULL
mouse	NULL
,	NULL
may	NULL
be	NULL
greater	NULL
than	NULL
hitherto	NULL
anticipated	NULL
and	NULL
that	NULL
glucocorticoids	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
proliferation/	NULL
differentiation	NULL
program	NULL
.	NULL

A	NULL
recent	NULL
report	NULL
described	NULL
a	NULL
similar	NULL
approach	NULL
to	NULL
grow	NULL
and	NULL
differentiate	NULL
primary	NULL
human	NULL
erythroblasts	NULL
.	NULL
``	NULL

In	NULL
this	NULL
report	NULL
,	NULL
the	NULL
differentiation	NULL
characteristics	NULL
of	NULL
these	NULL
cells	NULL
were	NULL
characterized	NULL
in	NULL
more	NULL
detail	NULL
.	NULL

In	NULL
avian	NULL
erythroblastosis	NULL
virus	NULL
(	NULL
AEV	NULL
)	NULL
-transformed	NULL
cells	NULL
,	NULL
a	NULL
mutated	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
(	NULL
v-ErbB	NULL
)	NULL
cooperates	NULL
with	NULL
a	NULL
mutated	NULL
nuclear	NULL
receptor	NULL
for	NULL
thyroid	NULL
hormone	NULL
(	NULL
v-ErbA	NULL
)	NULL
,	NULL
which	NULL
results	NULL
in	NULL
self-renewal	NULL
of	NULL
erythroid	NULL
progenitors	NULL
for	NULL
the	NULL
entire	NULL
in	NULL
vitro	NULL
life-span	NULL
of	NULL
a	NULL
chicken	NULL
cell	NULL
}	NULL
>	NULL
``	NULL
``	NULL
(	NULL
25	NULL
to	NULL
40	NULL
generations	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
normal	NULL
erythroid	NULL
progenitors	NULL
(	NULL
SCF/	NULL
TGFa	NULL
progenitors	NULL
)	NULL
could	NULL
be	NULL
identified	NULL
that	NULL
express	NULL
nonmutated	NULL
members	NULL
of	NULL
receptor	NULL
tyrosine	NULL
kinases	NULL
and	NULL
nuclear	NULL
hormone	NULL
receptors	NULL
and	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
self-renewal	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
human	NULL
recombinant	NULL
TGFa	NULL
as	NULL
a	NULL
ligand	NULL
for	NULL
c-ErbB	NULL
,	NULL
avian	NULL
SCB	NULL
,	NULL
and	NULL
both	NULL
Dex	NULL
and	NULL
estradiol	NULL
as	NULL
steroid	NULL
ligands	NULL
.	NULL

Ligand	NULL
activation	NULL
of	NULL
both	NULL
the	NULL
steroid	NULL
hormone	NULL
receptors	NULL
and	NULL
the	NULL
tyrosine	NULL
kinases	NULL
was	NULL
essential	NULL
for	NULL
self-renewal	NULL
of	NULL
these	NULL
cells.4	NULL
``	NULL
:	NULL
``	NULL
``	NULL
These	NULL
progenitors	NULL
are	NULL
relatively	NULL
rare	NULL
,	NULL
being	NULL
present	NULL
at	NULL
frequencies	NULL
of	NULL
only	NULL
1	NULL
in	NULL
VON	NULL
LINDERN	NULL
ET	NULL
AL	NULL
15,000	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
more	NULL
abundant	NULL
avian	NULL
erythroid	NULL
progenitor	NULL
was	NULL
identified	NULL
(	NULL
EpoR-progenitors	NULL
,	NULL
occurring	NULL
at	NULL
a	NULL
frequency	NULL
of	NULL
1	NULL
in	NULL
400°°	NULL
)	NULL
,	NULL
which	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
Dex	NULL
for	NULL
self-renewal	NULL
.	NULL

``	NULL
*	NULL
``	NULL
The	NULL
life	NULL
span	NULL
of	NULL
these	NULL
EpoR-progenitors	NULL
was	NULL
shorter	NULL
than	NULL
that	NULL
of	NULL
SCF/TGFa	NULL
progenitors	NULL
(	NULL
15	NULL
to	NULL
20	NULL
generations	NULL
)	NULL
.	NULL

These	NULL
avian	NULL
progenitors	NULL
closely	NULL
correspond	NULL
to	NULL
those	NULL
obtained	NULL
in	NULL
the	NULL
cultures	NULL
of	NULL
human	NULL
erythroblasts	NULL
.	NULL

They	NULL
do	NULL
not	NULL
respond	NULL
to	NULL
EGF-like	NULL
ligands	NULL
or	NULL
estradiol	NULL
and	NULL
terminally	NULL
differentiate	NULL
upon	NULL
culture	NULL
progression	NULL
rather	NULL
than	NULL
entering	NULL
senescence	NULL
as	NULL
undifferentiated	NULL
cells	NULL
typical	NULL
of	NULL
the	NULL
SCF/TGFa	NULL
progenitors	NULL
.	NULL

Differentiation	NULL
of	NULL
avian	NULL
erythroid	NULL
progenitors	NULL
can	NULL
be	NULL
induced	NULL
at	NULL
any	NULL
time	NULL
by	NULL
removal	NULL
of	NULL
the	NULL
self-renewal	NULL
factors	NULL
(	NULL
TGFa	NULL
,	NULL
E2	NULL
,	NULL
and	NULL
Dex	NULL
or	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
Dex	NULL
,	NULL
respectively	NULL
)	NULL
and	NULL
addition	NULL
of	NULL
differentiation	NULL
factors	NULL
(	NULL
Epo	NULL
plus	NULL
insulin	NULL
)	NULL
.	NULL

Upon	NULL
differentiation	NULL
induction	NULL
,	NULL
the	NULL
cells	NULL
undergo	NULL
a	NULL
fixed	NULL
number	NULL
of	NULL
5	NULL
cell	NULL
divisions	NULL
,	NULL
during	NULL
which	NULL
cell	NULL
cycle	NULL
and	NULL
cell	NULL
size	NULL
control	NULL
is	NULL
profoundly	NULL
altered	NULL
.	NULL
``	NULL

''	NULL
The	NULL
human	NULL
progenitors	NULL
grown	NULL
from	NULL
bone	NULL
marrow	NULL
or	NULL
cord	NULL
blood	NULL
could	NULL
be	NULL
similarly	NULL
induced	NULL
to	NULL
differentiate	NULL
into	NULL
enucleated	NULL
red	NULL
blood	NULL
cells	NULL
,	NULL
when	NULL
the	NULL
proliferation	NULL
factors	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
and	NULL
Dex	NULL
were	NULL
replaced	NULL
by	NULL
the	NULL
differentiation	NULL
factors	NULL
Epo	NULL
and	NULL
insulin	NULL
.	NULL

The	NULL
cells	NULL
underwent	NULL
a	NULL
limited	NULL
number	NULL
of	NULL
divisions	NULL
,	NULL
became	NULL
rapidly	NULL
smaller	NULL
(	NULL
from	NULL
900	NULL
£L	NULL
in	NULL
the	NULL
progenitors	NULL
to	NULL
~250	NULL
{	NULL
L	NULL
in	NULL
the	NULL
mature	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
accumulated	NULL
hemoglobin	NULL
levels	NULL
comparable	NULL
to	NULL
peripheral	NULL
blood	NULL
erythrocytes	NULL
(	NULL
mean	NULL
cellular	NULL
hemoglobin	NULL
content	NULL
of	NULL
35	NULL
to	NULL
40	NULL
g/dL	NULL
;	NULL
M.v.L	NULL
.	NULL

,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
control	NULL
of	NULL
erythroid	NULL
proliferation	NULL
and	NULL
differentiation	NULL
is	NULL
comparable	NULL
in	NULL
mammalian	NULL
and	NULL
avian	NULL
progenitors	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
likely	NULL
that	NULL
previously	NULL
described	NULL
mechanisms	NULL
regulating	NULL
the	NULL
balance	NULL
of	NULL
self-renewal	NULL
versus	NULL
terminal	NULL
differentiation	NULL
in	NULL
avian	NULL
cells	NULL
similarly	NULL
control	NULL
the	NULL
balance	NULL
between	NULL
proliferation	NULL
and	NULL
differentiation	NULL
in	NULL
mammalian	NULL
Cultures	NULL
of	NULL
human	NULL
erythroid	NULL
progenitors	NULL
could	NULL
be	NULL
established	NULL
both	NULL
from	NULL
CD34-	NULL
and	NULL
CD34*	NULL
cells	NULL
,	NULL
predominantly	NULL
containing	NULL
cells	NULL
with	NULL
the	NULL
morphology	NULL
of	NULL
proerythroblasts	NULL
.	NULL

Cultures	NULL
initiated	NULL
from	NULL
CD34*	NULL
cells	NULL
only	NULL
contained	NULL
CD34~	NULL
cells	NULL
by	NULL
day	NULL
5	NULL
.	NULL

Cells	NULL
with	NULL
such	NULL
a	NULL
phenotype	NULL
are	NULL
generally	NULL
considered	NULL
to	NULL
be	NULL
(	NULL
post-	NULL
)	NULL
CFU-E	NULL
.	NULL

However	NULL
,	NULL
a	NULL
CFU-E	NULL
is	NULL
characterized	NULL
by	NULL
a	NULL
very	NULL
limited	NULL
proliferation	NULL
capacity	NULL
(	NULL
3	NULL
to	NULL
5	NULL
cell	NULL
divisions	NULL
)	NULL
.	NULL

Even	NULL
BFU-E	NULL
are	NULL
reported	NULL
to	NULL
undergo	NULL
a	NULL
maximum	NULL
of	NULL
10	NULL
cell	NULL
divi-sions	NULL
,	NULL
``	NULL
``	NULL
less	NULL
than	NULL
the	NULL
20	NULL
cell	NULL
divisions	NULL
induced	NULL
by	NULL
the	NULL
cooperation	NULL
of	NULL
cytokines	NULL
and	NULL
steroid	NULL
hormones	NULL
that	NULL
we	NULL
observed	NULL
in	NULL
our	NULL
cultures	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
committed	NULL
erythroid	NULL
progenitors	NULL
have	NULL
a	NULL
larger	NULL
expansion	NULL
capacity	NULL
than	NULL
hitherto	NULL
anticipated	NULL
.	NULL

Glucocorticoids	NULL
have	NULL
pleiotropic	NULL
effects	NULL
on	NULL
hematopoietic	NULL
cells	NULL
:	NULL
activation	NULL
of	NULL
the	NULL
GR	NULL
induces	NULL
apoptosis	NULL
in	NULL
lymphoid	NULL
and	NULL
myelomonocytic	NULL
cells	NULL
,	NULL
while	NULL
it	NULL
protects	NULL
granulocytes	NULL
from	NULL
apoptosis	NULL
``	NULL
®	NULL
and	NULL
stimulates	NULL
proliferation	NULL
of	NULL
erythroid	NULL
progeni-tors	NULL
``	NULL
(	NULL
this	NULL
report	NULL
)	NULL
.	NULL

Repression	NULL
of	NULL
macrophages	NULL
and	NULL
lymphocytes	NULL
is	NULL
caused	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
GR	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
transcription	NULL
factors	NULL
AP-1	NULL
and	NULL
NFkB	NULL
,	NULL
independent	NULL
of	NULL
DNA	NULL
binding	NULL
by	NULL
the	NULL
GR	NULL
,	NULL
which	NULL
results	NULL
in	NULL
repression	NULL
of	NULL
transcription	NULL
by	NULL
these	NULL
complexes	NULL
.	NULL

!	NULL

Several	NULL
members	NULL
of	NULL
the	NULL
NFB	NULL
family	NULL
are	NULL
also	NULL
expressed	NULL
in	NULL
erythroid	NULL
progenitors	NULL
.	NULL
``	NULL

However	NULL
,	NULL
repression	NULL
appears	NULL
not	NULL
essential	NULL
for	NULL
the	NULL
function	NULL
of	NULL
the	NULL
GR	NULL
in	NULL
erythroid	NULL
progenitors	NULL
.	NULL

Instead	NULL
,	NULL
proliferation	NULL
induction	NULL
of	NULL
avian	NULL
erythroid	NULL
cells	NULL
is	NULL
dependent	NULL
on	NULL
intact	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
domains	NULL
of	NULL
the	NULL
GR	NULL
.	NULL
``	NULL

We	NULL
recently	NULL
confirmed	NULL
this	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CORTICOSTEROIDS	NULL
ENHANCE	NULL
ERYTHROID	NULL
PROLIFERATION	NULL
557	NULL
CD34	NULL
``	NULL
(	NULL
2x	NULL
)	NULL
CD34*	NULL
g	NULL
$	NULL
R2	NULL
Ri	NULL
k	NULL
--	NULL
--	NULL
--	NULL
-A4	NULL
Fig	NULL
6	NULL
.	NULL

Erythroid	NULL
progenitors	NULL
16°	NULL
ta	NULL
12	NULL
``	NULL
``	NULL
``	NULL
IP	NULL
t	NULL
16°	NULL
16	NULL
162	NULL
P	NULL
1	NULL
can	NULL
be	NULL
grown	NULL
from	NULL
CD34+	NULL
and	NULL
CD34~	NULL
cell	NULL
fractions	NULL
.	NULL

Mononuclear	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
fractionated	NULL
into	NULL
CD34~	NULL
and	NULL
CD34+	NULL
fractions	NULL
using	NULL
Minimacs	NULL
columns	NULL
.	NULL

The	NULL
CD34-	NULL
fraction	NULL
was	NULL
repurified	NULL
using	NULL
the	NULL
same	NULL
columns	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
for	NULL
CD34	NULL
to	NULL
verify	NULL
the	NULL
C	NULL
_	NULL
BFU-E	NULL
purific	NULL
.	NULL

from	NULL
CD34*	NULL
purity	NULL
of	NULL
the	NULL
CD34-	NULL
and	NULL
CD34+	NULL
fraction	NULL
by	NULL
FACS	NULL
.	NULL

The	NULL
CD34+	NULL
cells	NULL
were	NULL
costained	NULL
with	NULL
CD71	NULL
(	NULL
hori-zontal	NULL
axis	NULL
)	NULL
and	NULL
CD38	NULL
(	NULL
vertical	NULL
axis	NULL
;	NULL
C	NULL
)	NULL
.	NULL

Only	NULL
CD34*	NULL
cells	NULL
were	NULL
gated	NULL
(	NULL
A	NULL
and	NULL
B	NULL
;	NULL
gate	NULL
R2	NULL
)	NULL
.	NULL

Fractions	NULL
highly	NULL
enriched	NULL
for	NULL
BFU-E	NULL
(	NULL
C	NULL
;	NULL
R4	NULL
,	NULL
high	NULL
CD71	NULL
,	NULL
medium	NULL
CD38	NULL
)	NULL
19	NULL
``	NULL
.	NULL

,	NULL
,	NULL
1g	NULL
``	NULL
192	NULL
CD	NULL
38	NULL
or	NULL
immature	NULL
blast	NULL
cells	NULL
(	NULL
C	NULL
;	NULL
R3	NULL
;	NULL
medium-low	NULL
CD71	NULL
,	NULL
medium-low	NULL
CD38	NULL
)	NULL
were	NULL
purified	NULL
by	NULL
sorting	NULL
.	NULL

CD34~-	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
,	NULL
the	NULL
sorted	NULL
BFU-E	NULL
FL3-HNFL3-Height	NULL
--	NULL
-	NULL
>	NULL
10+	NULL
Cumulative	NULL
cell	NULL
number	NULL
0	NULL
10+	NULL
102	NULL
40°	NULL
progenitors	NULL
(	NULL
0	NULL
)	NULL
,	NULL
and	NULL
the	NULL
sorted	NULL
FL1-HNFL1-Height	NULL
--	NULL
-	NULL
>	NULL
10°	NULL
immature	NULL
blast	NULL
cells	NULL
(	NULL
0	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
CFU-E	NULL
medium	NULL
supplemented	NULL
with	NULL
Epo	NULL
,	NULL
SCF	NULL
,	NULL
IGF-I	NULL
,	NULL
and	NULL
Dex	NULL
.	NULL

Cumulative	NULL
cell	NULL
numbers	NULL
were	NULL
calculated	NULL
(	NULL
D	NULL
)	NULL
.	NULL

notion	NULL
in	NULL
mice	NULL
carrying	NULL
a	NULL
mutated	NULL
GR	NULL
,	NULL
which	NULL
lacked	NULL
the	NULL
ability	NULL
to	NULL
transactivate	NULL
upon	NULL
hormone	NULL
binding	NULL
,	NULL
but	NULL
retained	NULL
transrepress-ing	NULL
activity	NULL
.	NULL
``	NULL

''	NULL
Erythroblasts	NULL
could	NULL
be	NULL
grown	NULL
from	NULL
fetal	NULL
livers	NULL
of	NULL
wild-type	NULL
mice	NULL
using	NULL
the	NULL
same	NULL
conditions	NULL
described	NULL
here	NULL
,	NULL
but	NULL
not	NULL
from	NULL
fetal	NULL
livers	NULL
of	NULL
the	NULL
GRdim/dim	NULL
mice	NULL
,	NULL
confirming	NULL
the	NULL
crucial	NULL
role	NULL
of	NULL
the	NULL
GR	NULL
and	NULL
its	NULL
transactivation	NULL
ability	NULL
in	NULL
mammalian	NULL
erythroblast	NULL
proliferation	NULL
.	NULL

Although	NULL
we	NULL
could	NULL
not	NULL
expand	NULL
erythroblasts	NULL
from	NULL
fetal	NULL
livers	NULL
of	NULL
mice	NULL
deficient	NULL
for	NULL
the	NULL
GR*	NULL
or	NULL
from	NULL
GRdim/dim	NULL
mice	NULL
,	NULL
``	NULL
these	NULL
mice	NULL
do	NULL
not	NULL
show	NULL
obvious	NULL
defects	NULL
in	NULL
normal	NULL
in	NULL
vivo	NULL
erythropoiesis	NULL
.	NULL

Studies	NULL
addressing	NULL
stress	NULL
erythropoiesis	NULL
in	NULL
mice	NULL
showed	NULL
that	NULL
upregulation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
(	NULL
BFU-E	NULL
and	NULL
CFU-E	NULL
)	NULL
on	NULL
anemia	NULL
induction	NULL
occurred	NULL
exclusively	NULL
in	NULL
the	NULL
spleen	NULL
and	NULL
required	NULL
a	NULL
functional	NULL
c-Kit	NULL
receptor	NULL
tyrosine	NULL
kinase	NULL
.	NULL
``	NULL

Recently	NULL
,	NULL
we	NULL
have	NULL
obtained	NULL
evidence	NULL
that	NULL
this	NULL
upregulation	NULL
of	NULL
spleen	NULL
erythroid	NULL
progenitors	NULL
in	NULL
anemic	NULL
mice	NULL
does	NULL
not	NULL
occur	NULL
in	NULL
the	NULL
GR	NULL
dim/dim	NULL
mice	NULL
(	NULL
A.	NULL
Bauer	NULL
and	NULL
H.B	NULL
.	NULL

,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Because	NULL
glucocorticoids	NULL
are	NULL
highly	NULL
upregulated	NULL
on	NULL
blood	NULL
loss	NULL
or	NULL
injury	NULL
,	NULL
the	NULL
GR	NULL
may	NULL
play	NULL
a	NULL
physiological	NULL
role	NULL
in	NULL
stress	NULL
erythropoiesis	NULL
.	NULL

104	NULL
T	NULL
T	NULL
CD	NULL
71	NULL
0	NULL
s	NULL
days	NULL
in	NULL
culture	NULL
I	NULL
I	NULL
10	NULL
15	NULL
The	NULL
GR	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
STAT5	NULL
,	NULL
resulting	NULL
in	NULL
enhanced	NULL
transcription	NULL
of	NULL
B-casein	NULL
.	NULL
``	NULL

''	NULL
Although	NULL
disputed	NULL
,	NULL
DNA	NULL
binding	NULL
by	NULL
the	NULL
GR	NULL
appears	NULL
important	NULL
for	NULL
its	NULL
synergistic	NULL
action	NULL
with	NULL
STAT5.44®	NULL
This	NULL
synergy	NULL
has	NULL
so	NULL
far	NULL
only	NULL
been	NULL
described	NULL
for	NULL
the	NULL
BB-casein	NULL
promoter	NULL
.	NULL

We	NULL
tested	NULL
expression	NULL
of	NULL
the	NULL
STATS	NULL
target	NULL
gene	NULL
CIS	NULL
in	NULL
primary	NULL
erythroid	NULL
progenitors	NULL
stimulated	NULL
with	NULL
or	NULL
without	NULL
Epo	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
Dex	NULL
or	NULL
the	NULL
GR-antagonist	NULL
ZK	NULL
.	NULL

Cis	NULL
expression	NULL
was	NULL
fully	NULL
dependent	NULL
on	NULL
Epo-induced	NULL
STAT5-phosphorylation	NULL
,	NULL
but	NULL
independent	NULL
of	NULL
GR	NULL
activation	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
could	NULL
not	NULL
demonstrate	NULL
synergy	NULL
between	NULL
STAT5	NULL
and	NULL
the	NULL
GR	NULL
in	NULL
erythroid	NULL
progenitors	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
that	NULL
this	NULL
mechanism	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
other	NULL
target	NULL
genes	NULL
.	NULL

Among	NULL
several	NULL
genes	NULL
tested	NULL
that	NULL
are	NULL
critical	NULL
for	NULL
erythroid	NULL
self-renewal	NULL
,	NULL
the	NULL
GR	NULL
induced	NULL
expression	NULL
of	NULL
c-myb	NULL
.	NULL

Notably	NULL
,	NULL
constitutive	NULL
expression	NULL
of	NULL
activated	NULL
Myb	NULL
(	NULL
v-Myb	NULL
)	NULL
abrogated	NULL
the	NULL
requirement	NULL
for	NULL
corticosteroids	NULL
.	NULL
``	NULL

Mice	NULL
deficient	NULL
in	NULL
Myb	NULL
die	NULL
at	NULL
day	NULL
15	NULL
of	NULL
gestation	NULL
when	NULL
they	NULL
are	NULL
severely	NULL
anemic	NULL
.	NULL

*	NULL
``	NULL
One	NULL
of	NULL
the	NULL
genes	NULL
regulated	NULL
by	NULL
c-Myb	NULL
is	NULL
c-Kit	NULL
.	NULL
``	NULL

In	NULL
the	NULL
cultured	NULL
erythroid	NULL
progenitors	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
GR	NULL
enhanced	NULL
expression	NULL
of	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

558	NULL
c-myb	NULL
,	NULL
c-Kit	NULL
,	NULL
and	NULL
the	NULL
erythroid	NULL
transcription	NULL
factor	NULL
RBTN2	NULL
.	NULL

One	NULL
mechanism	NULL
by	NULL
which	NULL
corticosteroids	NULL
cooperate	NULL
with	NULL
SCF	NULL
and	NULL
Epo	NULL
may	NULL
involve	NULL
maintenance	NULL
of	NULL
c-Kit	NULL
expression	NULL
.	NULL

SCF	NULL
is	NULL
required	NULL
to	NULL
delay	NULL
differentiation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
.	NULL
``	NULL

The	NULL
EpoR	NULL
appears	NULL
to	NULL
form	NULL
a	NULL
complex	NULL
with	NULL
c-Kit	NULL
,	NULL
``	NULL
and	NULL
cross-phosphorylation	NULL
of	NULL
the	NULL
receptors	NULL
has	NULL
been	NULL
reported	NULL
.	NULL
``	NULL

Constitutive	NULL
overexpression	NULL
of	NULL
c-Kit	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
corticosteroids	NULL
delays	NULL
differentiation	NULL
,	NULL
but	NULL
it	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
induce	NULL
self-renewal	NULL
of	NULL
avian	NULL
erythroid	NULL
progenitors	NULL
.	NULL

!	NULL
``	NULL

Thus	NULL
,	NULL
maintaining	NULL
c-Kit	NULL
expression	NULL
is	NULL
an	NULL
important	NULL
contribution	NULL
of	NULL
the	NULL
GR	NULL
to	NULL
sustained	NULL
proliferation	NULL
,	NULL
but	NULL
induction	NULL
of	NULL
renewal	NULL
divisions	NULL
most	NULL
likely	NULL
involves	NULL
additional	NULL
genes	NULL
controlled	NULL
by	NULL
the	NULL
GR	NULL
via	NULL
c-Myb	NULL
and	NULL
could	NULL
involve	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
RBTN2	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
Dr	NULL
B.	NULL
Royer-Pokora	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
the	NULL
TTG2/	NULL
RBTN2	NULL
probe	NULL
,	NULL
Eva	NULL
Deiner	NULL
and	NULL
Petra	NULL
Buchinger	NULL
for	NULL
expert	NULL
technical	NULL
assistance	NULL
,	NULL
Saskia	NULL
Buchwald	NULL
and	NULL
Dr	NULL
B.	NULL
Wognum	NULL
for	NULL
help	NULL
and	NULL
advice	NULL
in	NULL
FACS-sorting	NULL
of	NULL
cells	NULL
,	NULL
and	NULL
Drs	NULL
LP	NULL
Touw	NULL
and	NULL
T.	NULL
van	NULL
Dijk	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Alter	NULL
BP	NULL
:	NULL
Biology	NULL
of	NULL
erythropoiesis	NULL
.	NULL

Ann	NULL
NY	NULL
Acad	NULL
Sci	NULL
731:36	NULL
,	NULL
1994	NULL
2	NULL
.	NULL

Keller	NULL
G	NULL
:	NULL
Hematopoietic	NULL
stem	NULL
cells	NULL
.	NULL

Curr	NULL
Opin	NULL
Immunol	NULL
4:133	NULL
,	NULL
1992	NULL
3	NULL
.	NULL

Beug	NULL
H	NULL
,	NULL
Bauer	NULL
A	NULL
,	NULL
Dolznig	NULL
H	NULL
,	NULL
von	NULL
Lindern	NULL
M	NULL
,	NULL
Lobmayer	NULL
L	NULL
,	NULL
Mellitzer	NULL
G	NULL
,	NULL
Steinlein	NULL
P	NULL
,	NULL
Wessely	NULL
O	NULL
,	NULL
Mullner	NULL
E	NULL
:	NULL
Avian	NULL
erythropoiesis	NULL
and	NULL
erythroleukemia	NULL
:	NULL
Towards	NULL
understanding	NULL
the	NULL
role	NULL
of	NULL
the	NULL
biomol-ecules	NULL
involved	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1288	NULL
:	NULL
M35	NULL
,	NULL
1996	NULL
4	NULL
.	NULL

Pain	NULL
B	NULL
,	NULL
Woods	NULL
CM	NULL
,	NULL
Saez	NULL
J	NULL
,	NULL
Flickinger	NULL
T	NULL
,	NULL
Raines	NULL
M	NULL
,	NULL
Peyrol	NULL
S	NULL
,	NULL
Moscovici	NULL
C	NULL
,	NULL
Moscovici	NULL
MG	NULL
,	NULL
Kung	NULL
HJ	NULL
,	NULL
Jurdic	NULL
P	NULL
,	NULL
Samarut	NULL
J	NULL
:	NULL
EGF-R	NULL
as	NULL
a	NULL
hemopoietic	NULL
growth	NULL
factor	NULL
receptor	NULL
:	NULL
The	NULL
c-erbB	NULL
product	NULL
is	NULL
present	NULL
in	NULL
chicken	NULL
erythrocytic	NULL
progenitors	NULL
and	NULL
controls	NULL
their	NULL
self-renewal	NULL
.	NULL

Cell	NULL
65:37	NULL
,	NULL
1991	NULL
5	NULL
.	NULL

Schroeder	NULL
C	NULL
,	NULL
Gibson	NULL
L	NULL
,	NULL
Nordstrom	NULL
C	NULL
,	NULL
Beug	NULL
H	NULL
:	NULL
The	NULL
estrogen	NULL
receptor	NULL
cooperates	NULL
with	NULL
the	NULL
TGF	NULL
alpha	NULL
receptor	NULL
(	NULL
c-erbB	NULL
)	NULL
in	NULL
regulation	NULL
of	NULL
chicken	NULL
erythroid	NULL
progenitor	NULL
self-renewal	NULL
.	NULL

EMBO	NULL
J	NULL
12:951	NULL
,	NULL
1993	NULL
6	NULL
.	NULL

Hayman	NULL
MJ	NULL
,	NULL
Meyer	NULL
S	NULL
,	NULL
Martin	NULL
F	NULL
,	NULL
Steinlein	NULL
P	NULL
,	NULL
Beug	NULL
H	NULL
;	NULL
Self-renewal	NULL
and	NULL
differentiation	NULL
of	NULL
normal	NULL
avian	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
:	NULL
Regulatory	NULL
roles	NULL
of	NULL
the	NULL
TGF	NULL
alpha/c-ErbB	NULL
and	NULL
SCF/c-kit	NULL
receptors	NULL
.	NULL

Cell	NULL
74:157	NULL
,	NULL
1993	NULL
7	NULL
.	NULL

Wessely	NULL
0	NULL
,	NULL
Deiner	NULL
E	NULL
,	NULL
Beug	NULL
H	NULL
,	NULL
von	NULL
Lindern	NULL
M	NULL
:	NULL
The	NULL
glucocorticoid	NULL
receptor	NULL
is	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
the	NULL
decision	NULL
between	NULL
self	NULL
renewal	NULL
and	NULL
differentiation	NULL
in	NULL
erythroid	NULL
progenitors	NULL
.	NULL

EMBO	NULL
J	NULL
16:267	NULL
,	NULL
1997	NULL
8	NULL
.	NULL

Bauer	NULL
A	NULL
,	NULL
Ulrich	NULL
E	NULL
,	NULL
Andersson	NULL
M	NULL
,	NULL
Beug	NULL
H	NULL
,	NULL
von	NULL
Linden	NULL
M	NULL
:	NULL
Mechanism	NULL
of	NULL
transformation	NULL
by	NULL
v-ErbA	NULL
:	NULL
Replacement	NULL
of	NULL
steroid	NULL
hormone	NULL
receptor	NULL
function	NULL
in	NULL
self	NULL
renewal	NULL
induction	NULL
.	NULL

Oncogene	NULL
15:701	NULL
,	NULL
1997	NULL
9	NULL
.	NULL

Wu	NULL
H	NULL
,	NULL
Liu	NULL
X	NULL
,	NULL
Jaenisch	NULL
R	NULL
,	NULL
Lodish	NULL
HF	NULL
:	NULL
Generation	NULL
of	NULL
committed	NULL
erythroid	NULL
BFU-E	NULL
and	NULL
CFU-E	NULL
progenitors	NULL
does	NULL
not	NULL
require	NULL
erythropoietin	NULL
or	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
.	NULL

Cell	NULL
83:59	NULL
,	NULL
1995	NULL
10	NULL
.	NULL

Lin	NULL
CS	NULL
,	NULL
Lim	NULL
SK	NULL
,	NULL
D'Agati	NULL
V	NULL
,	NULL
Costantini	NULL
F	NULL
:	NULL
Differential	NULL
effects	NULL
of	NULL
an	NULL
erythropoietin	NULL
receptor	NULL
gene	NULL
disruption	NULL
on	NULL
primitive	NULL
and	NULL
definitive	NULL
erythropoiesis	NULL
.	NULL

Genes	NULL
Dev	NULL
10:154	NULL
,	NULL
1996	NULL
11	NULL
.	NULL

Broxmeyer	NULL
HE	NULL
,	NULL
Maze	NULL
R	NULL
,	NULL
Miyazawa	NULL
K	NULL
,	NULL
Carow	NULL
C	NULL
,	NULL
Hendrie	NULL
PC	NULL
,	NULL
Cooper	NULL
S	NULL
,	NULL
Hangoc	NULL
G	NULL
,	NULL
Vadhan-Raj	NULL
S	NULL
,	NULL
Lu	NULL
L	NULL
:	NULL
The	NULL
kit	NULL
receptor	NULL
and	NULL
its	NULL
ligand	NULL
,	NULL
steel	NULL
factor	NULL
,	NULL
as	NULL
regulators	NULL
of	NULL
hemopoiesis	NULL
.	NULL

Cancer	NULL
Cells	NULL
3:480	NULL
,	NULL
1991	NULL
12	NULL
.	NULL

Williams	NULL
DE	NULL
,	NULL
de	NULL
Vries	NULL
P	NULL
,	NULL
Namen	NULL
AE	NULL
,	NULL
Widmer	NULL
MB	NULL
,	NULL
Lyman	NULL
SD	NULL
:	NULL
The	NULL
Steel	NULL
factor	NULL
.	NULL

Dev	NULL
Biol	NULL
151:368	NULL
,	NULL
1992	NULL
13	NULL
.	NULL

Uoshima	NULL
N	NULL
,	NULL
Ozawa	NULL
M	NULL
,	NULL
Kimura	NULL
S	NULL
,	NULL
Tanaka	NULL
K	NULL
,	NULL
Wada	NULL
K	NULL
,	NULL
Kobayashi	NULL
Y	NULL
,	NULL
Kondo	NULL
M	NULL
:	NULL
Changes	NULL
in	NULL
c-Kit	NULL
expression	NULL
and	NULL
effects	NULL
of	NULL
SCF	NULL
during	NULL
VON	NULL
LINDERN	NULL
ET	NULL
AL	NULL
differentiation	NULL
of	NULL
human	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
91:30	NULL
,	NULL
1995	NULL
14	NULL
.	NULL

Wessely	NULL
O	NULL
,	NULL
Mellitzer	NULL
G	NULL
,	NULL
von	NULL
Lindern	NULL
M	NULL
,	NULL
Levitzki	NULL
A	NULL
,	NULL
Gazit	NULL
A	NULL
,	NULL
Ischenko	NULL
I	NULL
,	NULL
Hayman	NULL
MJ	NULL
,	NULL
Beug	NULL
H	NULL
;	NULL
Distinct	NULL
roles	NULL
of	NULL
the	NULL
receptor	NULL
tyrosine	NULL
kinases	NULL
c-ErbB	NULL
and	NULL
c-Kit	NULL
in	NULL
regulating	NULL
the	NULL
balance	NULL
between	NULL
erythroid	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
8:481	NULL
,	NULL
1997	NULL
15	NULL
.	NULL

Muta	NULL
K	NULL
,	NULL
Krantz	NULL
SB	NULL
,	NULL
Bondurant	NULL
MC	NULL
,	NULL
Dai	NULL
CH	NULL
:	NULL
Stem	NULL
cell	NULL
factor	NULL
retards	NULL
differentiation	NULL
of	NULL
normal	NULL
human	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
while	NULL
stimulating	NULL
proliferation	NULL
.	NULL

Blood	NULL
86:572	NULL
,	NULL
1995	NULL
16	NULL
.	NULL

Beato	NULL
M	NULL
,	NULL
Herrlich	NULL
P	NULL
,	NULL
Schutz	NULL
G	NULL
:	NULL
Steroid	NULL
hormone	NULL
receptors	NULL
:	NULL
Many	NULL
actors	NULL
in	NULL
search	NULL
of	NULL
a	NULL
plot	NULL
.	NULL

Cell	NULL
83:851	NULL
,	NULL
1995	NULL
17	NULL
.	NULL

Golde	NULL
DW	NULL
,	NULL
Bersch	NULL
N	NULL
,	NULL
Cline	NULL
MJ	NULL
:	NULL
Potentiation	NULL
of	NULL
erythropoiesis	NULL
in	NULL
vitro	NULL
by	NULL
dexamethasone	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
57:57	NULL
,	NULL
1976	NULL
18	NULL
.	NULL

Dainiak	NULL
N	NULL
,	NULL
Hoffman	NULL
R	NULL
,	NULL
Ritchey	NULL
AK	NULL
,	NULL
Floyd	NULL
V	NULL
,	NULL
Callahan	NULL
M	NULL
:	NULL
In	NULL
vitro	NULL
steroid	NULL
sensitivity	NULL
testing	NULL
:	NULL
A	NULL
possible	NULL
means	NULL
to	NULL
predict	NULL
response	NULL
to	NULL
therapy	NULL
in	NULL
primary	NULL
hypoproliferative	NULL
anemia	NULL
.	NULL

Am	NULL
J	NULL
Hematol	NULL
9:401	NULL
,	NULL
1980	NULL
19	NULL
.	NULL

Billat	NULL
CL	NULL
,	NULL
Felix	NULL
JM	NULL
,	NULL
Jacquot	NULL
RL	NULL
:	NULL
In	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
regulation	NULL
of	NULL
hepatic	NULL
erythropoiesis	NULL
by	NULL
erythropoietin	NULL
and	NULL
glucocorticoids	NULL
in	NULL
the	NULL
rat	NULL
fetus	NULL
.	NULL

Exp	NULL
Hematol	NULL
10:133	NULL
,	NULL
1982	NULL
20	NULL
.	NULL

Amylon	NULL
MD	NULL
,	NULL
Perrine	NULL
SP	NULL
,	NULL
Glader	NULL
BE	NULL
:	NULL
Prednisone	NULL
stimulation	NULL
of	NULL
erythropoiesis	NULL
in	NULL
leukemic	NULL
children	NULL
during	NULL
remission	NULL
.	NULL

Am	NULL
J	NULL
Hematol	NULL
23:179	NULL
,	NULL
1986	NULL
21	NULL
.	NULL

Kowenz	NULL
E	NULL
,	NULL
Leutz	NULL
A	NULL
,	NULL
Doderlein	NULL
G	NULL
,	NULL
Graf	NULL
T	NULL
,	NULL
Beug	NULL
H	NULL
:	NULL
Ts-oncogene-transformed	NULL
erythroleukemic	NULL
cells	NULL
:	NULL
A	NULL
novel	NULL
test	NULL
system	NULL
for	NULL
purifying	NULL
and	NULL
characterizing	NULL
avian	NULL
erythroid	NULL
growth	NULL
factors	NULL
,	NULL
in	NULL
Neth	NULL
R	NULL
,	NULL
Gallo	NULL
RC	NULL
,	NULL
Greaves	NULL
MF	NULL
,	NULL
Kabish	NULL
H	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Modern	NULL
Trends	NULL
in	NULL
Human	NULL
Leukemia	NULL
VIL	NULL
.	NULL

Heidelberg	NULL
,	NULL
Germany	NULL
,	NULL
Springer-Verlag	NULL
,	NULL
1987	NULL
,	NULL
p	NULL
199	NULL
22	NULL
.	NULL

Beug	NULL
H	NULL
,	NULL
Palmieri	NULL
S	NULL
,	NULL
Freudenstein	NULL
C	NULL
,	NULL
Zentgraf	NULL
H	NULL
,	NULL
Graf	NULL
T	NULL
:	NULL
Hormone-dependent	NULL
terminal	NULL
differentiation	NULL
in	NULL
vitro	NULL
of	NULL
chicken	NULL
erythro-leukemia	NULL
cells	NULL
transformed	NULL
by	NULL
ts	NULL
mutants	NULL
of	NULL
avian	NULL
erythroblastosis	NULL
virus	NULL
.	NULL

Cell	NULL
28:907	NULL
,	NULL
1982	NULL
23	NULL
.	NULL

Chomezynski	NULL
P	NULL
,	NULL
Sacchi	NULL
N	NULL
:	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
Biochem	NULL
162:156	NULL
,	NULL
1987	NULL
24	NULL
.	NULL

Maniatis	NULL
T	NULL
,	NULL
Fritsch	NULL
EF	NULL
,	NULL
Sambrook	NULL
J	NULL
:	NULL
;	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
1982	NULL
25	NULL
.	NULL

Steinlein	NULL
P	NULL
,	NULL
Wessely	NULL
O	NULL
,	NULL
Meyer	NULL
S	NULL
,	NULL
Deiner	NULL
EM	NULL
,	NULL
Hayman	NULL
MJ	NULL
,	NULL
Beug	NULL
H	NULL
:	NULL
Primary	NULL
,	NULL
self-renewing	NULL
erythroid	NULL
progenitors	NULL
develop	NULL
through	NULL
activation	NULL
of	NULL
both	NULL
tyrosine	NULL
kinase	NULL
and	NULL
steroid	NULL
hormone	NULL
receptors	NULL
.	NULL

Curr	NULL
Biol	NULL
5:191	NULL
,	NULL
1995	NULL
26	NULL
.	NULL

Wessely	NULL
0	NULL
,	NULL
Bauer	NULL
A	NULL
,	NULL
Tran-Quang	NULL
C	NULL
,	NULL
von	NULL
Lindern	NULL
M	NULL
,	NULL
Deiner	NULL
EM	NULL
,	NULL
Steinlein	NULL
P	NULL
,	NULL
Ghysdael	NULL
J	NULL
,	NULL
Beug	NULL
H	NULL
:	NULL
A	NULL
novel	NULL
way	NULL
to	NULL
induce	NULL
erythroid	NULL
progenitor	NULL
self	NULL
renewal	NULL
:	NULL
Cooperation	NULL
of	NULL
c-Kit	NULL
with	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
.	NULL

Biol	NULL
Chem	NULL
380:187	NULL
,	NULL
1999	NULL
27	NULL
.	NULL

Panzenbock	NULL
B	NULL
,	NULL
Bartunek	NULL
P	NULL
,	NULL
Mapara	NULL
MY	NULL
,	NULL
Zenke	NULL
M	NULL
:	NULL
Growth	NULL
and	NULL
differentiation	NULL
of	NULL
human	NULL
stem	NULL
cell	NULL
factor/erythropoietin-dependent	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Blood	NULL
92:3658	NULL
,	NULL
1998	NULL
28	NULL
.	NULL

Warren	NULL
AJ	NULL
,	NULL
Colledge	NULL
WH	NULL
,	NULL
Carlton	NULL
MB	NULL
,	NULL
Evans	NULL
MJ	NULL
,	NULL
Smith	NULL
AJ	NULL
,	NULL
Rabbitts	NULL
TH	NULL
:	NULL
The	NULL
oncogenic	NULL
cystein-rich	NULL
LIM	NULL
domain	NULL
protein	NULL
rbtn2	NULL
is	NULL
essential	NULL
for	NULL
erythroid	NULL
development	NULL
.	NULL

Cell	NULL
78:45	NULL
,	NULL
1994	NULL
29	NULL
.	NULL

Pevay	NULL
L	NULL
,	NULL
Lin	NULL
CS	NULL
,	NULL
D	NULL
'	NULL
Agati	NULL
V	NULL
,	NULL
Simon	NULL
MC	NULL
,	NULL
Orkin	NULL
SH	NULL
,	NULL
Costantini	NULL
F	NULL
:	NULL
Development	NULL
of	NULL
hematopoietic	NULL
cells	NULL
lacking	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

Development	NULL
121:163	NULL
,	NULL
1995	NULL
30	NULL
.	NULL

Fujiwara	NULL
Y	NULL
,	NULL
Browne	NULL
CP	NULL
,	NULL
Cunniff	NULL
K	NULL
,	NULL
Goff	NULL
SC	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Arrested	NULL
development	NULL
of	NULL
embryonic	NULL
red	NULL
cell	NULL
precursors	NULL
in	NULL
mouse	NULL
embryos	NULL
lacking	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
93	NULL
:	NULL
12355	NULL
,	NULL
1996	NULL
31	NULL
.	NULL

Beug	NULL
H	NULL
,	NULL
Wessely	NULL
O	NULL
,	NULL
von	NULL
Lindern	NULL
M	NULL
:	NULL
Verfahren	NULL
zur	NULL
Herstellung	NULL
und	NULL
Ziichtung	NULL
hi	NULL
@	NULL
matopoetischer	NULL
Vorliuferzellen	NULL
,	NULL
Case	NULL
14/025	NULL
(	NULL
exten-sion	NULL
)	NULL
DI	NULL
Fa/tst	NULL
,	NULL
Boehringer	NULL
Ingelheim	NULL
International	NULL
GMBH	NULL
,	NULL
55216	NULL
Ingelheim	NULL
am	NULL
Rhein	NULL
,	NULL
BRD	NULL
,	NULL
1996	NULL
32	NULL
.	NULL

Hayman	NULL
MJ	NULL
,	NULL
Beug	NULL
H	NULL
:	NULL
Avian	NULL
erythroblastosis	NULL
:	NULL
A	NULL
model	NULL
system	NULL
to	NULL
study	NULL
oncogene	NULL
co-operation	NULL
in	NULL
leukemia	NULL
.	NULL

Cancer	NULL
Surv	NULL
15:53	NULL
,	NULL
1992	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CORTICOSTEROIDS	NULL
ENHANCE	NULL
ERYTHROID	NULL
PROLIFERATION	NULL
33	NULL
.	NULL

Beug	NULL
H	NULL
,	NULL
Mullner	NULL
EW	NULL
,	NULL
Hayman	NULL
MJ	NULL
:	NULL
Insights	NULL
into	NULL
erythroid	NULL
differentiation	NULL
obtained	NULL
from	NULL
studies	NULL
on	NULL
avian	NULL
erythroblastosis	NULL
virus	NULL
.	NULL

Curr	NULL
Opin	NULL
Cell	NULL
Biol	NULL
6:816	NULL
,	NULL
1994	NULL
34	NULL
.	NULL

Bauer	NULL
A	NULL
,	NULL
Mikulits	NULL
W	NULL
,	NULL
Lagger	NULL
G	NULL
,	NULL
Stengl	NULL
!	NULL

G	NULL
,	NULL
Brosch	NULL
G	NULL
,	NULL
Beug	NULL
H	NULL
:	NULL
The	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
functions	NULL
as	NULL
a	NULL
ligand-operated	NULL
,	NULL
developmental	NULL
switch	NULL
between	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
.	NULL

EMBO	NULL
J	NULL
17:4291	NULL
,	NULL
1998	NULL
35	NULL
.	NULL

Dolznig	NULL
H	NULL
,	NULL
Bartunek	NULL
P	NULL
,	NULL
Nasmyth	NULL
K	NULL
,	NULL
Mullner	NULL
EW	NULL
,	NULL
Beug	NULL
H	NULL
:	NULL
;	NULL
Terminal	NULL
differentiation	NULL
of	NULL
normal	NULL
chicken	NULL
erythroid	NULL
progenitors	NULL
:	NULL
Shortening	NULL
of	NULL
G1	NULL
correlates	NULL
with	NULL
loss	NULL
of	NULL
D-cyclin/cdk4	NULL
expression	NULL
and	NULL
altered	NULL
cell	NULL
size	NULL
control	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
6:1341	NULL
,	NULL
1995	NULL
36	NULL
.	NULL

Miillner	NULL
EW	NULL
,	NULL
Dolznig	NULL
H	NULL
,	NULL
Beug	NULL
H	NULL
:	NULL
Cell	NULL
cycle	NULL
regulation	NULL
and	NULL
erythroid	NULL
differentiation	NULL
,	NULL
in	NULL
Vainio	NULL
0	NULL
,	NULL
Imhof	NULL
BA	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Immunology	NULL
and	NULL
Developmental	NULL
Biology	NULL
of	NULL
the	NULL
Chicken	NULL
.	NULL

Current	NULL
Topics	NULL
in	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Springer	NULL
Verlag	NULL
,	NULL
1996	NULL
,	NULL
p	NULL
171	NULL
37	NULL
.	NULL

Marley	NULL
SB	NULL
,	NULL
Amos	NULL
TAS	NULL
,	NULL
Gordon	NULL
MY	NULL
:	NULL
Kinetics	NULL
of	NULL
colony	NULL
formation	NULL
by	NULL
BFU-E	NULL
grown	NULL
under	NULL
different	NULL
culture	NULL
conditions	NULL
in	NULL
vitro	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
92:559	NULL
,	NULL
1996	NULL
38	NULL
.	NULL

Liles	NULL
WC	NULL
,	NULL
Dale	NULL
DC	NULL
,	NULL
Klebanoff	NULL
SJ	NULL
:	NULL
;	NULL
Glucocorticoids	NULL
inhibit	NULL
apoptosis	NULL
of	NULL
human	NULL
neutrophils	NULL
.	NULL

Blood	NULL
86:3181	NULL
,	NULL
1995	NULL
39	NULL
.	NULL

Zhang	NULL
MY	NULL
,	NULL
Sun	NULL
SC	NULL
,	NULL
Bell	NULL
L	NULL
,	NULL
Miller	NULL
BA	NULL
:	NULL
NF-kappaB	NULL
transcription	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
normal	NULL
erythropoiesis	NULL
.	NULL

Blood	NULL
91:4136	NULL
,	NULL
1998	NULL
40	NULL
.	NULL

Reichardt	NULL
HM	NULL
,	NULL
Kaestner	NULL
KH	NULL
,	NULL
Tuckermann	NULL
J	NULL
,	NULL
Kretz	NULL
O	NULL
,	NULL
Wessely	NULL
O	NULL
,	NULL
Bock	NULL
R	NULL
,	NULL
Gass	NULL
P	NULL
,	NULL
Schmid	NULL
W	NULL
,	NULL
Herrlich	NULL
P	NULL
,	NULL
Angel	NULL
P	NULL
,	NULL
Schutz	NULL
G	NULL
:	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
survival	NULL
.	NULL

Cell	NULL
93:531	NULL
,	NULL
1998	NULL
41	NULL
.	NULL

Cole	NULL
PJ	NULL
,	NULL
Blendy	NULL
JA	NULL
,	NULL
Monaghan	NULL
AP	NULL
,	NULL
Kriegelstein	NULL
K	NULL
,	NULL
Schmid	NULL
W	NULL
,	NULL
Aguzzi	NULL
A	NULL
,	NULL
Fantuzzi	NULL
G	NULL
,	NULL
Hummler	NULL
E	NULL
,	NULL
Unsicker	NULL
K	NULL
,	NULL
Schiitz	NULL
G	NULL
:	NULL
Targeted	NULL
disruption	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
gene	NULL
blocks	NULL
adrenergic	NULL
chromaffin	NULL
cell	NULL
development	NULL
and	NULL
severely	NULL
retards	NULL
lung	NULL
maturation	NULL
.	NULL

Genes	NULL
Dev	NULL
9:1608	NULL
,	NULL
1995	NULL
42	NULL
.	NULL

Broudy	NULL
VC	NULL
,	NULL
Lin	NULL
NL	NULL
,	NULL
Priestley	NULL
GV	NULL
,	NULL
Nocka	NULL
K	NULL
,	NULL
Wolf	NULL
NS	NULL
:	NULL
Interaction	NULL
of	NULL
stem	NULL
cell	NULL
factor	NULL
and	NULL
its	NULL
receptor	NULL
c-kit	NULL
mediates	NULL
lodgment	NULL
and	NULL
acute	NULL
expansion	NULL
of	NULL
hematopoietic	NULL
cells	NULL
in	NULL
the	NULL
murine	NULL
spleen	NULL
.	NULL

Blood	NULL
88:75	NULL
,	NULL
1996	NULL
43	NULL
.	NULL

Stocklin	NULL
E	NULL
,	NULL
Wissler	NULL
M	NULL
,	NULL
Gouilleux	NULL
F	NULL
,	NULL
Groner	NULL
B	NULL
:	NULL
Functional	NULL
interactions	NULL
between	NULL
Stats	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

Nature	NULL
383:726	NULL
,	NULL
1996	NULL
44	NULL
.	NULL

Cella	NULL
N	NULL
,	NULL
Groner	NULL
B	NULL
,	NULL
Hynes	NULL
NE	NULL
:	NULL
Characterization	NULL
of	NULL
StatSa	NULL
and	NULL
559	NULL
StatSb	NULL
homodimers	NULL
and	NULL
heterodimers	NULL
and	NULL
their	NULL
association	NULL
with	NULL
the	NULL
glucocortiocoid	NULL
receptor	NULL
in	NULL
mammary	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
18:1783	NULL
,	NULL
1998	NULL
45	NULL
.	NULL

Lechner	NULL
J	NULL
,	NULL
Welte	NULL
T	NULL
,	NULL
Doppler	NULL
W	NULL
:	NULL
Mechanism	NULL
of	NULL
interaction	NULL
between	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
and	NULL
Stat5	NULL
:	NULL
Role	NULL
of	NULL
DNA-binding	NULL
.	NULL

Immunobiology	NULL
198:112	NULL
,	NULL
1997	NULL
46	NULL
.	NULL

Stoecklin	NULL
E	NULL
,	NULL
Wissler	NULL
M	NULL
,	NULL
Morigg	NULL
!	NULL

R	NULL
,	NULL
Groner	NULL
B	NULL
:	NULL
Specific	NULL
DNA	NULL
binding	NULL
of	NULL
Stat5	NULL
,	NULL
but	NULL
not	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
,	NULL
is	NULL
required	NULL
for	NULL
their	NULL
functional	NULL
cooperation	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
17:6708	NULL
,	NULL
1997	NULL
47	NULL
.	NULL

Yoshimura	NULL
A	NULL
,	NULL
Ohkubo	NULL
T	NULL
,	NULL
Kiguchi	NULL
T	NULL
,	NULL
Jenkins	NULL
NA	NULL
,	NULL
Gilbert	NULL
DJ	NULL
,	NULL
Copeland	NULL
NG	NULL
,	NULL
Hara	NULL
T	NULL
,	NULL
Miyajima	NULL
A	NULL
:	NULL
A	NULL
novel	NULL
cytokine-inducible	NULL
gene	NULL
CIS	NULL
encodes	NULL
an	NULL
SH2-containing	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
tyrosine-phosphorylated	NULL
interleukin	NULL
3	NULL
and	NULL
erythropoietin	NULL
receptors	NULL
.	NULL

EMBO	NULL
J	NULL
14:2816	NULL
,	NULL
1995	NULL
48	NULL
.	NULL

Mucenski	NULL
ML	NULL
,	NULL
McLain	NULL
K	NULL
,	NULL
Kier	NULL
AB	NULL
,	NULL
Swerdlow	NULL
SH	NULL
,	NULL
Schreiner	NULL
CM	NULL
,	NULL
Miller	NULL
TA	NULL
,	NULL
Pictryga	NULL
DW	NULL
,	NULL
Scott	NULL
WJ	NULL
Jr	NULL
,	NULL
Potter	NULL
SS	NULL
:	NULL
A	NULL
functional	NULL
c-myb	NULL
gene	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
murine	NULL
fetal	NULL
hepatic	NULL
hematopoiesis	NULL
.	NULL

Cell	NULL
65:677	NULL
,	NULL
1991	NULL
49	NULL
.	NULL

Ratajczak	NULL
MZ	NULL
,	NULL
Perrotti	NULL
D	NULL
,	NULL
Melotti	NULL
P	NULL
,	NULL
Powzaniuk	NULL
M	NULL
,	NULL
Calabretta	NULL
B	NULL
,	NULL
Onodera	NULL
K	NULL
,	NULL
Kregenow	NULL
DA	NULL
,	NULL
Machalinski	NULL
B	NULL
,	NULL
Gewirtz	NULL
AM	NULL
:	NULL
Myb	NULL
and	NULL
ets	NULL
proteins	NULL
are	NULL
candidate	NULL
regulators	NULL
of	NULL
c-kit	NULL
expression	NULL
in	NULL
human	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Blood	NULL
91:1934	NULL
,	NULL
1998	NULL
50	NULL
.	NULL

Vandenbark	NULL
GR	NULL
,	NULL
Chen	NULL
Y	NULL
,	NULL
Friday	NULL
E	NULL
,	NULL
Pavlik	NULL
K	NULL
,	NULL
Anthony	NULL
B	NULL
,	NULL
deCastro	NULL
C	NULL
,	NULL
Kaufman	NULL
RE	NULL
:	NULL
Complex	NULL
regulation	NULL
of	NULL
human	NULL
c-kit	NULL
transcription	NULL
by	NULL
promoter	NULL
repressors	NULL
,	NULL
activators	NULL
,	NULL
and	NULL
specific	NULL
myb	NULL
elements	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
7:1383	NULL
,	NULL
1996	NULL
51	NULL
.	NULL

Broudy	NULL
VC	NULL
,	NULL
Lin	NULL
NL	NULL
,	NULL
Buhring	NULL
HJ	NULL
,	NULL
Komatsu	NULL
N	NULL
,	NULL
Kavanagh	NULL
TJ	NULL
:	NULL
Analysis	NULL
of	NULL
c-kit	NULL
receptor	NULL
dimerization	NULL
by	NULL
fluorescence	NULL
resonance	NULL
energy	NULL
transfer	NULL
.	NULL

Blood	NULL
91:898	NULL
,	NULL
1998	NULL
52	NULL
.	NULL

Wu	NULL
H	NULL
,	NULL
Klingmuller	NULL
U	NULL
,	NULL
Besmer	NULL
P	NULL
,	NULL
Lodish	NULL
HF	NULL
:	NULL
Interaction	NULL
of	NULL
the	NULL
erythropoietin	NULL
and	NULL
stem-cell-factor	NULL
receptors	NULL
.	NULL

Nature	NULL
377:242	NULL
,	NULL
1995	NULL
53	NULL
.	NULL

Wu	NULL
H	NULL
,	NULL
Klingmullet	NULL
U	NULL
,	NULL
Acurio	NULL
A	NULL
,	NULL
Hsiao	NULL
JG	NULL
,	NULL
Lodish	NULL
HF	NULL
:	NULL
Functional	NULL
interaction	NULL
of	NULL
erythropoietin	NULL
and	NULL
stem	NULL
cell	NULL
factor	NULL
receptors	NULL
is	NULL
essential	NULL
for	NULL
erythroid	NULL
colony	NULL
formation	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
94:1806	NULL
,	NULL
1997	NULL
54	NULL
.	NULL

Jacobs-Helber	NULL
SM	NULL
,	NULL
Penta	NULL
K	NULL
,	NULL
Sun	NULL
Z	NULL
,	NULL
Lawson	NULL
A	NULL
,	NULL
Sawyer	NULL
ST	NULL
:	NULL
Distinct	NULL
signaling	NULL
from	NULL
stem	NULL
cell	NULL
factor	NULL
and	NULL
erythropoietin	NULL
in	NULL
HCDS57	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
272:6850	NULL
,	NULL
1997	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blO	NULL
Od®	NULL
1999	NULL
94	NULL
:	NULL
550-559	NULL
The	NULL
Glucocorticoid	NULL
Receptor	NULL
Cooperates	NULL
With	NULL
the	NULL
Erythropoietin	NULL
Receptor	NULL
and	NULL
c-Kit	NULL
to	NULL
Enhance	NULL
and	NULL
Sustain	NULL
Proliferation	NULL
of	NULL
Erythroid	NULL
Progenitors	NULL
In	NULL
Vitro	NULL
Marieke	NULL
von	NULL
Lindern	NULL
,	NULL
Wolfgang	NULL
Zauner	NULL
,	NULL
Georg	NULL
Mellitzer	NULL
,	NULL
Peter	NULL
Steinlein	NULL
,	NULL
Gerhard	NULL
Fritsch	NULL
,	NULL
Klaus	NULL
Huber	NULL
,	NULL
Bob	NULL
Lowenberg	NULL
and	NULL
Hartmut	NULL
Beug	NULL
A	NULL
_	NULL
48	NULL
o	NULL
6	NULL
'	NULL
t	NULL
“	NULL
f.9	NULL
'	NULL
.	NULL
'	NULL

e	NULL
>	NULL
\	NULL
/	NULL
{	NULL
®	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/94/2/550.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Hematopoiesis	NULL
and	NULL
Stem	NULL
Cells	NULL
(	NULL
3573	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

